<SEC-DOCUMENT>0001213900-25-043423.txt : 20250514
<SEC-HEADER>0001213900-25-043423.hdr.sgml : 20250514
<ACCEPTANCE-DATETIME>20250514171800
ACCESSION NUMBER:		0001213900-25-043423
CONFORMED SUBMISSION TYPE:	S-3/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250514
DATE AS OF CHANGE:		20250514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RICHTECH ROBOTICS INC.
		CENTRAL INDEX KEY:			0001963685
		STANDARD INDUSTRIAL CLASSIFICATION:	GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569]
		ORGANIZATION NAME:           	06 Technology
		EIN:				882870106
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		S-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-284779
		FILM NUMBER:		25947113

	BUSINESS ADDRESS:	
		STREET 1:		4175 CAMERON ST STE 1
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89103
		BUSINESS PHONE:		8662363835

	MAIL ADDRESS:	
		STREET 1:		4175 CAMERON ST STE 1
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89103
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3/A
<SEQUENCE>1
<FILENAME>ea0242170-s3a2_richtech.htm
<DESCRIPTION>AMENDMENT NO. 2 TO FORM S-3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>As filed with the Securities and Exchange
Commission on May 14, 2025</B> </P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <b>Registration No. 333-284779</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Amendment No. 2 to</B> </P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM S-3</b></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RICHTECH ROBOTICS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3569</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>86-2870106</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary Standard Industrial</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation or organization)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification Code Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification Number)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4175 Cameron St Ste 1<BR>
Las Vegas, NV 89103<BR>
(866) 236-3835</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,
including area code, of registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Zhenwu (Wayne) Huang<BR>
c/o Richtech Robotics Inc.<BR>
4175 Cameron St Ste 1<BR>
Las Vegas, NV 89103<BR>
(866) 236-3835</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Please send a copy of all communications to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Richard I. Anslow, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Lijia Sanchez, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ellenoff Grossman&nbsp;&amp; Schole LLP<BR>
1345 Avenue of the Americas, 11<SUP>th</SUP> Floor<BR>
New&nbsp;York, New&nbsp;York 10105<BR>
Telephone: (212)&nbsp;370-1300<BR>
Fax: (212)&nbsp;370-7889</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximate date of commencement proposed sale
to the public: From time to time after the effective date of this Registration Statement.</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the only securities being registered on this
Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered
only in connection with dividend or interest reinvestment plans, check the following box. &#9746;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a registration statement pursuant
to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.:</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 52%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</FONT></TD>
    <TD STYLE="width: 17%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 31%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer &#9746;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company &#9746;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company &#9746;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. &#9744;</P>


<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>The Registrant
hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with
Section&nbsp;8(a)&nbsp;of the Securities Act, or until the registration statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <b>EXPLANATORY NOTE</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> This registration statement
contains two prospectuses: </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"> &#9679; </td><td style="text-align: justify"> a base prospectus, which covers
                                            the offering, issuance and sale by us from time to time of up to $200,000,000 of our Class
                                            B common stock, preferred stock, purchase contracts, warrants, subscriptions rights, depositary
                                            shares, debt securities and/or units, in one or more offerings, with an aggregate initial
                                            offering price of $200,000,000; and </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"> &#9679; </td><td style="text-align: justify"> a prospectus which covers the
                                            possible resale from time to time by a selling stockholder of up to 2,699,797 shares of our
                                            Class B common stock. </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The base prospectus immediately
follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in
a prospectus supplement to the base prospectus. The resale prospectus immediately follows the base prospectus. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information in
this prospectus is not complete and may be changed. We may not sell the securities until the Registration Statement filed with the Securities
and Exchange Commission, of which this prospectus is a part, is effective. This prospectus is not an offer to sell these securities and
is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="color: Red"><B>SUBJECT TO COMPLETION,
DATED MAY 14, 2025</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RICHTECH ROBOTICS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$200,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: center"><B>CLASS B COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PREFERRED STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURCHASE CONTRACTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUBSCRIPTION RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEPOSITARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEBT SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may offer and sell from
time to time, in one or more series, any one of the following securities of Richtech Robotics Inc. (&ldquo;Richtech,&rdquo; the &ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;), for total gross proceeds of up to $200,000,000:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class B common stock, par value $0.0001 per share (the &ldquo;Class B Common Stock&rdquo; or the &ldquo;Common Stock&rdquo;);</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: top">
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preferred stock;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: top">
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchase contracts;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: top">
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase our securities;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: top">
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subscription rights to purchase any of the foregoing securities;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: top">
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">depositary shares;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: top">
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">secured or unsecured debt securities consisting of notes, debentures or other evidences of indebtedness which may be senior debt securities, senior subordinated debt securities or subordinated debt securities, each of which may be convertible into equity securities; or</FONT></TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: top">
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">units comprised of, or other combinations of, the foregoing securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may offer and sell these
securities separately or together, in one or more series or classes and in amounts, at prices and on terms described in one or more offerings.
We may offer securities through underwriting syndicates managed or co-managed by one or more underwriters or dealers, through agents or
directly to purchasers. The prospectus supplement for each offering of securities will describe in detail the plan of distribution for
that offering. For general information about the distribution of securities offered, please see &ldquo;Plan of Distribution&rdquo; in
this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each time our securities are
offered, we will provide a prospectus supplement containing more specific information about the particular offering and attach it to this
prospectus. The prospectus supplements may also add, update or change information contained in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>This prospectus may not
be used to offer or sell securities without a prospectus supplement which includes a description of the method and terms of this offering.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Our Class B Common Stock
is listed on The Capital Market of The Nasdaq Stock Market LLC (&ldquo;Nasdaq Capital Market&rdquo;) under the symbol &ldquo;RR.&rdquo;
The last reported sale price of our Class B Common Stock on May 13, 2025 was $2.27 per share. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-size: 8pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we decide to seek a listing
of any preferred stock, purchase contracts, warrants, subscriptions rights, depositary shares, debt securities or units offered by this
prospectus, the related prospectus supplement will disclose the exchange or market on which the securities will be listed, if any, or
where we have made an application for listing, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <B>We are an &ldquo;emerging
growth company&rdquo; as that term is used in the Jumpstart Our Business Startups Act of 2012 and as such, we have elected to take advantage
of certain reduced public company reporting requirements for this prospectus and future filings. See &ldquo;Prospectus Summary &mdash;
Implications of Being an Emerging Growth Company.&rdquo;</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
involves certain risks. See &ldquo;Risk Factors&rdquo; beginning on page 6 and the risk factors in our most recent Annual Report on
Form 10-K/A, which is incorporated by reference herein, as well as in any other recently filed quarterly or current reports and, if any,
in the relevant prospectus supplement. We urge you to carefully read this prospectus and any applicable prospectus supplement, together
with the documents we incorporate by reference, describing the terms of these securities before investing.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this Prospectus is _____________, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 92%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 8%; text-align: center"><B>Page</B></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About This Prospectus</FONT></A></TD>
    <TD STYLE="text-align: center">ii</TD></TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary Statement Regarding Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">iii</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus Summary</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">1</TD></TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">6</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">7</TD></TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">8</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities We May Offer</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">11</TD></TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forms of Securities</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">25</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Matters</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">27</TD></TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">27</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where You Can Find Additional Information</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">27</TD></TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation of Documents By Reference</FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">27</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt">This prospectus is part of
a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or SEC, utilizing a &ldquo;shelf&rdquo;
registration process. Under this shelf registration process, we may offer and sell, either individually or in combination, in one or more
offerings, any of the securities described in this prospectus, for total gross proceeds of up to $200,000,000. This prospectus provides
you with a general description of the securities we may offer. Each time we offer securities under this prospectus, we will provide a
prospectus supplement to this prospectus that will contain more specific information about the terms of that offering. We may also authorize
one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus
supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the
information contained in this prospectus or in the documents that we have incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt">We urge you to read carefully
this prospectus, any applicable prospectus supplement and any free writing prospectuses we have authorized for use in connection with
a specific offering, together with the information incorporated herein by reference as described under the heading &ldquo;Incorporation
of Documents by Reference,&rdquo; before investing in any of the securities being offered. You should rely only on the information contained
in, or incorporated by reference into, this prospectus and any applicable prospectus supplement, along with the information contained
in any free writing prospectuses we have authorized for use in connection with a specific offering. We have not authorized anyone to provide
you with different or additional information. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances
and in jurisdictions where it is lawful to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information appearing
in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the date on the
front of the document and any information we have incorporated by reference is accurate only as of the date of the document incorporated
by reference, regardless of the time of delivery of this prospectus, any applicable prospectus supplement or any related free writing
prospectus, or any sale of a security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus contains summaries
of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete
information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to
herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus
is a part, and you may obtain copies of those documents as described below under the section entitled &ldquo;Where You Can Find Additional
Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt">This prospectus contains,
or incorporates by reference, trademarks, tradenames, service marks and service names of Richtech and its subsidiaries.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and the documents
incorporated by reference herein contain or may contain forward looking statements that involve risks and uncertainties. All statements
other than statements of historical fact contained in this prospectus and the documents incorporated by reference herein, including statements
regarding future events, our future financial performance, business strategy, and plans and objectives of management for future operations,
are forward-looking statements. We have attempted to identify forward-looking statements by terminology including &ldquo;anticipates,&rdquo;
&ldquo;believes,&rdquo; &ldquo;can,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo;
&ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;plans,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo; &ldquo;should,&rdquo;
or &ldquo;will&rdquo; or the negative of these terms or other comparable terminology. The following factors among others, could cause
actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to secure raw materials and components to manufacture sufficient quantities of robots to match demand;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to secure enterprise clients and deals in the face of growing competition;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
around the speed of robotic adoption in service environments;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
relating to the size of the market for our products and services;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unanticipated
regulations of robots and automation that add barriers to adoption and have a negative effect on our business;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to obtain and maintain intellectual property protection for our products;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
estimates of expenses, future revenue, capital requirements and our needs for, or ability to obtain, additional financing;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to attract or maintain a qualified workforce;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
possibility that we may be adversely affected by other economic, business, and/or competitive factors; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
risks and uncertainties described under the section titled &ldquo;Risk Factors&rdquo; in this prospectus.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we do not make forward
looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are
only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under &ldquo;Risk
Factors&rdquo; or elsewhere in this prospectus and the documents incorporated by reference herein, which may cause our or our industry&rsquo;s
actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Moreover, we
operate in a highly regulated, very competitive, and rapidly changing environment. New risks emerge from time to time and it is not possible
for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or
combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have based these forward-looking
statements largely on our current expectations and projections about future events and financial trends that we believe may affect our
financial condition, results of operations, business strategy, short term and long term business operations, and financial needs. These
forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from
those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited
to, those discussed in this prospectus, and in particular, the risks discussed below and under the heading &ldquo;Risk Factors&rdquo;
and those discussed in other documents we file with the SEC. The following discussion should be read in conjunction with the consolidated
financial statements for the fiscal years ended September 30, 2024 and 2023 and notes incorporated by reference herein. We undertake no
obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. In
light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus may not
occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should not place undue
reliance on any forward-looking statement, each of which applies only as of the date of this prospectus. Except as required by law, we
undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this prospectus to conform
our statements to actual results or changed expectations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any forward-looking statement
you read in this prospectus, any prospectus supplement or any document incorporated by reference reflects our current views with respect
to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, operating results,
growth strategy and liquidity. You should not place undue reliance on these forward-looking statements because such statements speak only
as to the date when made. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to
update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information
becomes available in the future, except as otherwise required by applicable law. You are advised, however, to consult any further disclosures
we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the SEC. You should understand that it is not possible
to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks
or uncertainties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 3pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights
selected information contained elsewhere in this prospectus. This summary does not contain all the information that you should consider
before investing in our Company. You should carefully read the entire prospectus, including all documents incorporated by reference herein.
In particular, attention should be directed to our &ldquo;Risk Factors,&rdquo; &ldquo;Information With Respect to the Company,&rdquo;
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and the financial statements
and related notes thereto contained herein or otherwise incorporated by reference hereto, before making an investment decision.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used herein, and any amendment
or supplement hereto, unless otherwise indicated, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; the &ldquo;Company,&rdquo; or
&ldquo;Richtech&rdquo; means Richtech Robotics Inc., including its consolidated subsidiaries. Unless otherwise indicated, all references
in this prospectus to &ldquo;dollars&rdquo; or &ldquo;$&rdquo; refer to US dollars.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a developer of advanced
robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented
labor shortages. With a global R&amp;D team based out of China and the United States, we design, manufacture and sell robots to restaurants,
hotels, senior living centers, casinos, factories, movie theaters and other businesses. Our robots perform a variety of services including
restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. We design
our robots to be friendly, customizable to client environments, and extremely reliable. For example, our food service delivery robots
typically make over 1000 deliveries every month in busy environments, while our medical robots are utilized for tasks such as delivering
medications and supplies in hospitals, enhancing operational efficiency. Our current customer base includes major hotel brands, national
chain restaurants, leading senior care facilities, and top casino management companies, and prominent healthcare institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our mission is to integrate
robotics and automation into our everyday lives. We envision ourselves becoming the first robotics &ldquo;Super-operator,&rdquo; where
thousands of our robots are deployed out in the field and managed by Richtech&rsquo;s AI Cloud Platform (ACP). As a Super-operator, our
robotic fleet will be performing a wide variety of tasks within a business, from completing deliveries and scrubbing floors to cooking
noodles, preparing drinks, and supporting logistics in hospitals. Our ACP platform will allow businesses to plug in their robots and immediately
leverage an immense amount of data to optimize workflows, lower management complexity, and minimize labor dependency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Products and Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are categorized
into three kinds of service automation: indoor transport and delivery, sanitation, and food and beverage automation. Our target market
is the hospitality sector, which includes restaurants, hotels, casinos, resorts, senior care, hospitals, and movie theaters. We also plan
to leverage our expertise in food automation to bring services directly to the consumer with the ADAM system which is described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The majority of our robots
can be characterized as Autonomous Mobile Robots (&ldquo;AMRs&rdquo;), meaning that our robots can understand and move through its environment
independently. AMRs differ from their predecessors, Autonomous Guided Vehicles (&ldquo;AGVs&rdquo;), which rely on tracks or predefined
paths and often require operator oversight. Our AMRs understand their environment through an array of advanced sensors, with the primary
sensor being a LiDAR which stands for Light Detection and Ranging. The LiDAR is able to create a 2D map of the environment by sending
out laser pulses and measuring the time it takes to bounce back, similar to sonar but far more accurate. Secondary sensors such as RGBD
cameras that detect color and depth of images, ultrasonic proximity sensors, and standard AI machine vision that can recognize objects
are used in sync to create an in-depth understanding of the robot&rsquo;s environment. These sensors, combined with a robust navigation
software stack based on AI algorithms, provides our robots the ability to perform dynamic path planning through their environments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 3pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ACP service is a business
optimization tool that allows customers to benefit from the rich operational data generated by the robots. Each AMR can operate independently
in the real world and report data up to the ACP. The ACP can then utilize the data to optimize workflows, enhance guest experiences, and
minimize waste. The ACP will store robot utilization metrics for analyses and reporting, providing clients with detailed operational data.
Lastly, one of the most important features of the ACP is that it allows multiple types of robots to operate in the same environment, utilizing
the same integrations and providing data back to a centralized point.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Indoor Transport and Delivery</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the transport and delivery
category we have four main product lines, the Matradee line of server assistant robots geared towards restaurants and restaurant-like
environments, the Medbot line designed specifically for hospital deliveries, the Titan line for heavy duty payloads in central distribution
facilities and general transport duties, and the Skylark line of service robots customized for hotel and room service applications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Matradee</I></B> is
a robot designed for dining spaces that can be used for bussing, serving, hosting, advertising, and entertaining. For example, Matradee
will transport food from the kitchen to the table where a waiter can come by and serve the guests. The waiter could then load the Matradee
with dirty plates and send it to the dish washing zone in the kitchen. This keeps the waiter on the floor serving guests and reduces physical
stress on the waiter. The robot is designed to operate in narrow and busy environments, navigating around tables and people in order to
get to its destination. Typically, a Matradee will perform over 1000 deliveries per month in a busy restaurant. On the ACP, clients can
review number of deliveries, distance traveled, hours of operation, utilization patterns over time, and manage their robotic fleet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Matradee was designed to
have a large carrying capacity and to be able to carry as much food as three to four waiters combined per trip. The robot is designed
to be extremely stable so that it can carry wine glasses and delicate food items without spilling. It can also be used to greet guests
at the reception area and lead them to their table. With a battery life of eight to fourteen-hours between charges, the Matradee can run
for the entire day without taking a break. When multiple robots are deployed in the same space, the robots communicate over short-range
radio waves to coordinate and make way for each other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 3pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">One of the biggest advantages
of the Matradee is the ease of deployment and reliability. Standard deployments involving full installation and staff training are typically
completed within three to four hours. The robot is not connectivity dependent and can operate fully offline. These features decrease the
difficulty of deployments and dramatically increase the variety of environments in which the Matradee can be deployed successfully. This
allows more deployments, lower costs, and faster scaling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Matradee is currently
deployed in restaurants, hotels, casinos, senior living homes, and factories. Many of these businesses have either restaurants or have
restaurants-like businesses so the primary task the robot performs is delivering food from the kitchen to the tables, and bussing dirty
dishes back to the dishpit. Some factory clients also utilize the Matradee for delivery of parts by making use of the remote summoning
feature to call the robot to specific stations to pick up items for delivery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Medbot </I></B>is designed
specifically for secure and efficient deliveries in hospitals and other healthcare spaces. This line of robots is a rebranding of the
Richie/Robbie robotic line to help customers better associate the robot to specific applications. The robot has 4 secured compartments
that can be configured to deliver items to up to 4 different destinations per trip. Through our ACP, the Medbot can travel on elevators
and through secure doors providing a fully autonomous delivery solution in extremely dynamic environments. The Medbot has a very robust
suite of sensors that allows it to be very nimble and intelligent when navigating highly complex unstructured environments around people
as well as large obstructions like hospital beds and trash bins. From our deployments in the field, a fleet of 5 Medbots can make around
8,000 deliveries per month, traveling over 600 miles, with over 600 hours of active runtime between them. This alleviates one of the toughest
tasks on hospital staff, and provides a very strong return on investment (&ldquo;ROI&rdquo;) for the hospital. We expect to launch multiple
pilot installations in fiscal year 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Titan</I></B> is the
newest addition to our delivery robot lineup, adding an option for customers looking for more heavy duty AMR delivery options. The current
version of Titan can carry between 330 to 440 pounds, with additional models able to carry over 1,000 pounds in development. Titan was
designed with modularity and ease of implementation in mind, as it can lift any rack as long as the rack meets a certain set of general
parameters. This provides Titan with a very large addressable market in and outside the hospitality space. For example, factories and
warehouses can utilize Titan for delivery of large objects over large spaces, up and down elevators and through secure doors. Titan broadens
the applications where we can apply our AMR technology to improve efficiency and solve labor challenges. We believe that Titan will play
a large role in increasing the total number of robots deployed due to its broad applicability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Skylark</I></B> represents
a set of robots that are designed specifically for hotel and applications where room service is an element of the client&rsquo;s business.
This product&rsquo;s addressable market primarily consists of hotels, senior living, and apartment buildings. The design of Skylark revolves
around modularity, and adaptability to the environment it is deployed in. The system consists of a base navigation module and several
modular attachments specialized for specific tasks such as delivery or cleaning. Currently, the Skylark has a cleaning attachment for
vacuuming and mopping floors, and a enclosed delivery attachment for room service and package delivery. Additional attachments are scheduled
for release in the future, including a security and laundry attachment. One important element of Skylark is that all attachments are customized
specifically for the hotel environment. This means the design accounts for common issues such as door width, elevator navigation, and
specific low-obstacle avoidance problems not common in other AMR application scenarios. The modular Skylark robot provides an all-in-one
solution that emphasizes ROI and ease-of-use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 3pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Sanitation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>DUST-E</I></B> is our
autonomous commercial cleaning robot product line that features two distinct models the S and MX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The S is designed for medium
sized environments under 100,000 sq. ft. The primary use case for the S is in open commercial spaces such as lobbies of hotels and more
challenging surfaces such as those of restaurants where there may be food debris and spills. The S utilizes a high-power vacuum and multi-roller
system that categorizes the debris it picks up for a one-pass cleaning efficiency. The S comes with a number of advanced features including
a charging station, scheduled cleaning functions, and precise localization that brings down the wall gap to just three centimeters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Future models are expected
to include an AI driven categorization system that adjusts the cleaning routine according to the type and intensity of the mess being
cleaned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The MX is our largest unit
capable of cleaning spaces up to 500,000 sq ft. Designed with professional cleaning in mind, the MX is a floor scrubber tailored to large
industrial and commercial spaces such as warehouses, factories, large hotel floors, event spaces, schools and universities, and department
stores. The MX comes in a variety of configurations that accommodate different floor types from bare concrete to more sensitive vinyl
tiles. Designed for heavy-duty cleaning, the MX comes with a 30-gallon water tank, weighs over 600 lbs., and provides a brush pressure
of 13.2g/cm<SUP>2</SUP>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Data collected by the ACP
provide clients with utilization metrics as well as a cleaning map which show the path the robot took during its cleaning routine. The
ACP is expected to provide reminders for routine replacement of consumable and renewable components, and preemptive maintenance alerts
for all robots.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Food and Beverage Automation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ADAM is our food and beverage
automation robot developed on the NVIDIA Jetson Orin platform. The core concept of ADAM is to develop a fully independent food and beverage
business based entirely on robots and automation. The dual six-degree-of-freedom robotic arms are designed to provide the same level of
flexibility as a human arm, allowing ADAM to easily emulate human movements. We designed ADAM to be friendly and approachable by giving
it a white and round exterior, and designed it to look more like a robot than a human to avoid the &ldquo;uncanny valley&rdquo; effect.
(The uncanny valley is a concept that suggests that humanoid objects that imperfectly resemble actual human beings provoke uncanny or
strangely familiar feelings of uneasiness and revulsion in observers. &ldquo;Valley&rdquo; denotes a dip in the human observer&rsquo;s
affinity for the replica, a relation that otherwise increases with the replica&rsquo;s human likeness.) Future features are expected to
include adding natural language processing to allow customers to directly speak their orders to the robot as they would with an employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 3pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ADAM is capable of making
a wide variety of beverages including coffee, craft cocktails, and Boba tea autonomously. ADAM is currently serving customers at various
venues across the country including inside supermarkets, stadiums, hospitals, and coffee shops across the country. Since 2022, we have
rented the ADAM system out for corporate and celebrity events. Clients included global tech firms, accounting firms, global alcoholic
beverage companies, and U.S. celebrities. In fiscal year 2024, we accomplished $857,000 in revenue from leasing ADAM for events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Scorpion </I></B>is
a new product for 2025, developed on the same architecture as ADAM, Scorpion can perform many of ADAM&rsquo;s AI functions at a lower
cost and smaller footprint. Additional AI camera systems allow for new features such as gesture and face recognition. These additional
features, along with the smaller footprint, provide a more intimate experience for guests. Scorpion also has the unique ability to personalize
any traditional cocktail recipe. Just tell Scorpion what mood you are in, and it will craft a totally unique cocktail based on your input
and information collected through its sensors. The smaller footprint allows for this intelligent AI bartender to be deployed in a wider
variety of environments, providing a more engaging and unique experience, while significantly improving ROI and affordability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 17, 2024, we announced
our plans to launch 20 robotic restaurant locations in Walmart stores across the country. As of the date of this Report, two locations
have been secured via franchise agreements: (1) on September 10, 2024, the Company signed a franchise agreement for a new location in
Peachtree City, Georgia. This location, slated to commence operations in January 2025, will be operated by Alphamax Management LLC, a
wholly-owned subsidiary of the Company; and (2) on August 20, 2024, the Company amended an existing franchise agreement originally intended
for Clovis, California, relocating the franchise to Oceanside, California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Clouffee &amp; Tea</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Clouffee &amp; Tea is
our first self-owned restaurant brand. The concept behind Clouffee &amp; Tea is to seamlessly blend innovative technology with a vibrant
coffee and tea culture to create an engaging customer experience. Robotic operation presents a uniquely scalable franchise model, which
we plan to demonstrate as a successful blueprint for integrating robotics into coffee and tea shop operations. Beyond redefining the
beverage experience, Clouffee &amp; Tea will serve as a dynamic platform for technological application and iteration. It will allow us
to utilize real-world scenarios for testing new robotic technologies while opening an additional revenue growth channel for the Company.
Clouffee &amp; Tea, opened its inaugural franchise store in Las Vegas, Nevada in late January 2025, adding another dimension to our growth
strategy </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>Implications of Being an Emerging Growth Company</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We qualify as an &ldquo;emerging
growth company,&rdquo; as defined in the Jumpstart Our Business Startups Act&nbsp;of&nbsp;2012 (the &ldquo;JOBS Act&rdquo;). For as long
as we remain an emerging growth company, we may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies. These provisions include, but are not limited to: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">being permitted to have
only two&nbsp;years of audited financial statements and only two&nbsp;years of related selected financial data and management&rsquo;s
discussion and analysis of financial condition and results of operations disclosure;</FONT> </TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">an exemption from compliance
with the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to Section&nbsp;404
of the Sarbanes-Oxley Act&nbsp;of&nbsp;2002, as amended (the &ldquo;Sarbanes-Oxley Act&rdquo;);</FONT> </TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">reduced disclosure about
executive compensation arrangements in our periodic reports, registration statements, and proxy statements; and</FONT> </TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">exemptions from the requirements
to seek non-binding advisory votes on executive compensation or golden parachute arrangements.</FONT> </TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In addition, the JOBS
Act permits emerging growth companies to take advantage of an extended transition period to comply with new or revised accounting standards
applicable to public companies. We are not choosing to &ldquo;opt out&rdquo; of this provision. We will remain an emerging growth company
until the earliest of (i)&nbsp;the last&nbsp;day of the fiscal year following the fifth anniversary of the completion of this offering,
(ii)&nbsp;the last&nbsp;day of the first fiscal year in which our annual gross revenues exceed $1.235&nbsp;billion, (iii)&nbsp;the date
on which we have, during the immediately preceding three-year period, issued more than $1.0&nbsp;billion in non-convertible debt securities
and (iv)&nbsp;the end of any fiscal year in which the market value of our Class&nbsp;B common stock held by non-affiliates exceeds $700&nbsp;million
as of the end of the second quarter of that fiscal year. We have elected to take advantage of certain of the reduced disclosure obligations
in the registration statement of which this prospectus is a part and may elect to take advantage of other reduced reporting requirements
in future filings. As a result, the information that we provide to our stockholders may be different than you might receive from other
public reporting companies in which you hold equity interests. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal executive offices
are located at 4175 Cameron St Ste 1, Las Vegas, NV 89103, and our telephone number is (866) 236-3835. Our corporate website address is
<I>www.richtechrobotics.com</I>. The information contained on or accessible through our website is not a part of, and is not incorporated
by reference into, this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our securities
involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risk factors we
describe in any prospectus supplement and in any related free writing prospectus for a specific offering of securities, as well as those
incorporated by reference into this prospectus and any prospectus supplement. You should also carefully consider other information contained
and incorporated by reference in this prospectus and any applicable prospectus supplement, including our financial statements and the
related notes thereto incorporated by reference in this prospectus. The risks and uncertainties described in the applicable prospectus
supplement and our other filings with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) incorporated by reference herein
are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently consider immaterial may
also adversely affect us. If any of the described risks occur, our business, financial condition or results of operations could be materially
harmed. In such case, the value of our securities could decline and you may lose all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated
in a prospectus supplement, we intend to use the net proceeds from these sales for general corporate purposes. The amounts and timing
of these expenditures will depend on numerous factors, including the development of our current business initiatives. We have no specific
acquisition contemplated at this time. Pending use of the net proceeds, we intend to invest the net proceeds in short-term, interest-bearing,
investment-grade securities or in cash or money market funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
from time to time to or through underwriters or dealers, through agents, or directly to one or more purchasers. A distribution of the
securities offered by this prospectus may also be effected through the issuance of derivative securities, including without limitation,
warrants, rights to purchase and subscriptions. In addition, the manner in which we may sell some or all of the securities covered by
this prospectus includes, without limitation, through:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a block trade in which a broker-dealer will attempt to sell as agent, but may position or resell a portion of the block, as principal, in order to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases by a broker-dealer, as principal, and resale by the broker-dealer for its account; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions and transactions in which a broker solicits purchasers.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A prospectus supplement or
supplements with respect to each series of securities will describe the terms of the offering, including, to the extent applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms of the offering;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the name or names of the underwriters or agents and the amounts of securities underwritten or purchased by each of them, if any;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the public offering price or purchase price of the securities or other consideration therefor, and the proceeds to be received by us from the sale;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any delayed delivery requirements;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any over-allotment options under which underwriters may purchase additional securities from us;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any underwriting discounts or agency fees and other items constituting underwriters&rsquo; or agents&rsquo; compensation</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any discounts or concessions allowed or re-allowed or paid to dealers; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any securities exchange or market on which the securities may be listed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offer and sale of the
securities described in this prospectus by us, the underwriters or the third parties described above may be effected from time to time
in one or more transactions, including privately negotiated transactions, either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a fixed price or prices, which may be changed;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in an &ldquo;at the market&rdquo; offering within the meaning of Rule 415(a)(4) of the Securities Act of 1933, as amended, or the Securities Act;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at prices related to such prevailing market prices; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at negotiated prices.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only underwriters named in
the prospectus supplement will be underwriters of the securities offered by the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Underwriters and Agents; Direct Sales</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If underwriters are used in
a sale, they will acquire the offered securities for their own account and may resell the offered securities from time to time in one
or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time
of sale. We may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters
without a syndicate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the prospectus supplement
states otherwise, the obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable
underwriting agreement. Subject to certain conditions, the underwriters will be obligated to purchase all of the securities offered by
the prospectus supplement, other than securities covered by any over-allotment option. Any public offering price and any discounts or
concessions allowed or re-allowed or paid to dealers may change from time to time. We may use underwriters with whom we have a material
relationship. We will describe in the prospectus supplement, naming the underwriter, the nature of any such relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell securities directly
or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities, and we will
describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent
will act on a best-efforts basis for the period of its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may authorize agents or
underwriters to solicit offers by certain types of institutional investors to purchase securities from us at the public offering price
set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in
the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts in
the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dealers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the offered securities
to dealers as principals. The dealer may then resell such securities to the public either at varying prices to be determined by the dealer
or at a fixed offering price agreed to with us at the time of resale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Institutional Purchasers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may authorize agents, dealers
or underwriters to solicit certain institutional investors to purchase offered securities on a delayed delivery basis pursuant to delayed
delivery contracts providing for payment and delivery on a specified future date. The applicable prospectus supplement or other offering
materials, as the case may be, will provide the details of any such arrangement, including the offering price and commissions payable
on the solicitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will enter into such delayed
contracts only with institutional purchasers that we approve. These institutions may include commercial and savings banks, insurance companies,
pension funds, investment companies and educational and charitable institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Indemnification; Other Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may provide agents, underwriters,
dealers and remarketing firms with indemnification against certain civil liabilities, including liabilities under the Securities Act,
or contribution with respect to payments that the agents or underwriters may make with respect to these liabilities. Agents, underwriters,
dealers and remarketing firms, and their affiliates, may engage in transactions with, or perform services for, us in the ordinary course
of business. This includes commercial banking and investment banking transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Market-Making; Stabilization and Other Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is currently no market
for any of the offered securities, other than our Class B Common Stock, which is quoted on the Nasdaq Capital Market. If the offered securities
are traded after their initial issuance, they may trade at a discount from their initial offering price, depending upon prevailing interest
rates, the market for similar securities and other factors. While it is possible that an underwriter could inform us that it intends to
make a market in the offered securities, such underwriter would not be obligated to do so, and any such market-making could be discontinued
at any time without notice. Therefore, no assurance can be given as to whether an active trading market will develop for the offered securities.
We have no current plans for listing of the debt securities, preferred stock, warrants or subscription rights on any securities exchange
or quotation system; any such listing with respect to any particular debt securities, preferred stock, warrants or subscription rights
will be described in the applicable prospectus supplement or other offering materials, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any underwriter may engage
in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Securities
Exchange Act of 1934, as amended, or the Exchange Act. Over-allotment involves sales in excess of the offering size, which create a short
position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified
maximum price. Syndicate-covering or other short-covering transactions involve purchases of the securities, either through exercise of
the over-allotment option or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the
underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing
or covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise
be. If commenced, the underwriters may discontinue any of the activities at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any underwriters or agents
that are qualified market makers on the Nasdaq Capital Market may engage in passive market making transactions in our Class B Common Stock
or redeemable listed warrants on the Nasdaq Capital Market in accordance with Regulation M under the Exchange Act, during the business
day prior to the pricing of the offering, before the commencement of offers or sales of our Class B Common Stock or redeemable listed
warrants. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers.
In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if
all independent bids are lowered below the passive market maker&rsquo;s bid, however, the passive market maker&rsquo;s bid must then be
lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above
that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Fees and Commissions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If 5% or more of the net proceeds
of any offering of securities made under this prospectus will be received by a FINRA member participating in the offering or affiliates
or associated persons of such FINRA member, the offering will be conducted in accordance with FINRA Rule 5121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>DESCRIPTION OF SECURITIES WE MAY OFFER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus describes
the general terms of our capital stock. The following description is not complete and may not contain all the information you should consider
before investing in our capital stock. For a more detailed description of these securities, you should read the applicable provisions
of Nevada law and our second amended and restated articles of incorporation, referred to herein as our charter, and our second amended
and restated bylaws, referred to herein as our bylaws. When we offer to sell a particular series of these securities, we will describe
the specific terms of the series in a supplement to this prospectus. Accordingly, for a description of the terms of any series of securities,
you must refer to both the prospectus supplement relating to that series and the description of the securities described in this prospectus.
To the extent the information contained in the prospectus supplement differs from this summary description, you should rely on the information
in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our authorized capital stock
consists of an aggregate of 300,000,000 shares of common stock, including 100,000 shares of Class A common stock, $0.0001 par value per
share (the &ldquo;Class A Common Stock&rdquo;) and 200,000,000 shares of Class B Common Stock, and 10,000,000 shares of &ldquo;blank check&rdquo;
preferred stock, par value $0.0001 per share. Our authorized but unissued shares of common stock and preferred stock are available for
issuance without further action by our stockholders, unless such action is required by applicable law or the rules of any stock exchange
or automated quotation system on which our securities may be listed or traded in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We, directly or through agents,
dealers or underwriters designated from time to time, may offer, issue and sell, together or separately, up to $200,000,000 in the aggregate
of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class B Common Stock;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preferred stock;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchase contracts;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase our securities;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subscription rights to purchase our securities;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">depositary shares;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">secured or unsecured debt securities consisting of notes, debentures or other evidences of indebtedness which may be senior debt securities, senior subordinated debt securities or subordinated debt securities, each of which may be convertible into equity securities; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">units comprised of, or other combinations of, the foregoing securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We may issue the debt
securities exchangeable for or convertible into shares of common stock or preferred stock that may be sold by us pursuant to this prospectus
or any combination of the foregoing. The preferred stock may also be exchangeable for and/or convertible into shares of common stock
or another series of preferred stock that may be sold by us pursuant to this prospectus or any combination of the foregoing. When a particular
series of securities is offered, a supplement to this prospectus will be delivered with this prospectus, which will set forth the terms
of the offering and sale of the offered securities. We will not issue any securities exchangeable or convertible into securities that
have not been registered on the registration statement of which this prospectus forms a part, unless such convertible or exchangeable
securities are not exercisable or convertible within one year of the date of sale of the convertible or exchangeable security. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As of May 13, 2025, there
were 74,868,935 shares of the Company&rsquo;s Class&nbsp;B Common Stock issued and outstanding and 39,934,846 shares of the Company&rsquo;s
Class&nbsp;A Common Stock issued and outstanding. In addition, there were 4,345,357 shares of Class&nbsp;B Common Stock issuable upon
exercise of outstanding warrants, 896,036 shares of Class&nbsp;B Common Stock issuable upon exercise of outstanding stock options, and
478,000 shares of Class&nbsp;B Common Stock issuable upon vesting of restricted stock units. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as otherwise required
by Nevada Revised Statutes (&ldquo;NRS&rdquo;), each holder of Class A Common Stock is entitled to ten (10) votes in respect of each share
of Class A Common Stock held by him, her, or it of record on the books of the Company, and each holder of Class B Common Stock is entitled
to one (1) vote in respect of each share of Class B Common Stock held by him, her, or it of record on the books of the Company, in connection
with the election of directors and on all matters submitted to a vote of stockholders of the Company. Each share of Class A Common Stock
is convertible into one share of Class B Common Stock at any time at the option of the holder, but Class B Common Stock shall not be convertible
into Class A Common Stock under any circumstances. Holders of our common stock do not have preemptive, subscription, or redemption rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Class&nbsp;B Common Stock
is listed on the Nasdaq Capital Market under the trading symbol &ldquo;RR.&rdquo; The transfer agent and registrar for our Class&nbsp;B
Common Stock is Continental Stock Transfer&nbsp;&amp; Trust Company. The Transfer Agent&rsquo;s address is 1 State Street, 30<SUP>th </SUP>Floor,
New&nbsp;York, New&nbsp;York 10004.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As of May 13, 2025, we
have 1,000,000 shares of preferred stock authorized, all of which are undesignated, and no shares of preferred stock outstanding. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our charter, our
board of directors may by resolution authorize the issuance of shares of preferred stock from time to time in one or more series. We may
reissue shares of preferred stock that are redeemed, purchased, or otherwise acquired by us unless otherwise provided by law. Our board
of directors is authorized to fix or alter the designations, powers and preferences, and relative, participating, optional or otherwise
rights if any, and qualifications, limitations or restrictions thereof, including, without limitation, dividend rights (and whether dividends
are cumulative), conversion rights, if any, voting rights (including the number of votes if any, per share, as well as the number of members,
if any, of the board of directors or the percentage of members, if any, of the board of directors each class or series of preferred stock
may be entitled to elect), rights and terms of redemption (including, sinking fund provisions, if any), redemption price and liquidation
preferences of any wholly unissued series of preferred stock, and the number of shares constituting any such series and the designation
thereof, and to increase or decrease the number of shares of any such series subsequent to the issuance of shares of such series, but
not below the number of shares of such series then issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with any offering
of undesignated preferred stock, we will fix the rights, preferences, privileges and restrictions of the preferred stock of each series
in the certificate of designation relating to that series. We will file as an exhibit to the registration statement of which this prospectus
is a part, or will incorporate by reference from a current report on Form 8-K that we file with the SEC, the form of any certificate of
designation that describes the terms of the series of preferred stock we are offering before the issuance of the related series of preferred
stock. This description will include any or all of the following, as required:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the title and stated value;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares we are offering;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the liquidation preference per share;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the purchase price;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the dividend rate, period and payment date and method of calculation for dividends;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any contractual limitations on our ability to declare, set aside or pay any dividends;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the procedures for any auction and remarketing, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the provisions for a sinking fund, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase rights;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any listing of the preferred stock on any securities exchange or market;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether the preferred stock will be convertible into our common stock, and, if applicable, the conversion price, or how it will be calculated, and the conversion period;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price, or how it will be calculated, and the exchange period;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting rights, if any, of the preferred stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preemptive rights, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions on transfer, sale or other assignment, if any;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether interests in the preferred stock will be represented by depositary shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a discussion of any material or special United States federal income tax considerations applicable to the preferred stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we issue shares of preferred
stock under this prospectus, after receipt of payment therefor, the shares will be fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors may
authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights
of the holders of our common stock. Preferred stock could be issued quickly with terms designed to delay or prevent a change in control
of our Company or make removal of management more difficult. Additionally, the issuance of preferred stock could have the effect of decreasing
the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Anti-takeover&nbsp;Effects of Nevada Law
and Our Charter and Bylaws</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Special Stockholder Meetings</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide that special
meetings of our stockholders may be called at any time by a resolution adopted by any three or more directors, and may not be called by
any other person or persons. Our bylaws prohibit the conduct of any business at a special meeting other than as specified in the notice
for such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Requirements for Advance Notification of Director
Nominations and Stockholder Proposals</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws establish advance
notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors. In order for any matter
to be properly brought before a meeting of our stockholders, the stockholder submitting the proposal or nomination will have to comply
with advance notice requirements and provide us with certain information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For business to be properly
brought before an annual meeting, the proposing stockholder must have given written notice of the nomination or proposal, either by personal
delivery or by United&nbsp;States mail to the Secretary not later than the close of business on the ninetieth (90<SUP>th</SUP>) day nor
earlier than the close of business on the one hundred twentieth (120<SUP>th</SUP>) day prior to the first anniversary date of the preceding
year&rsquo;s annual meeting. If the date of the annual meeting is advanced more than thirty (30) days prior to such anniversary date or
delayed more than seventy (70) days after such anniversary date then to be timely such notice must be so delivered, or mailed and received,
not later than the ninetieth (90<SUP>th</SUP>) day prior to such annual meeting or, if later, the tenth (10<SUP>th</SUP>) day following
the day on which public announcement of the date of such annual meeting was first made. In no event will an adjournment or postponement
of an annual meeting of stockholders begin a new time period for giving a proposing stockholder&rsquo;s notice as provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For business to be properly
brought before a special meeting of stockholders, the notice of the meeting must set forth the nature of the business to be considered.
A person or persons who have properly made a written request for a special meeting may provide the information required for notice of
a stockholder proposal simultaneously with the written request for the meeting submitted to the Secretary or within ten calendar&nbsp;days
after delivery of the written request for the meeting to the Secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws also specify requirements
as to the form and content of the stockholder&rsquo;s notice and allow the chairman of the meeting to prescribe rules and regulations
for the conduct of stockholders&rsquo; meetings, which may preclude the conduct of certain business at a meeting if the rules and regulations
are not followed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Authorized but Unissued Capital Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither Nevada law nor our
governing documents require stockholder approval for any issuance of authorized shares, except as provided in NRS 78.2055 with respect
to a decrease in the number of issued and outstanding shares of a class or series without a corresponding decrease in the authorized shares.
Our authorized but unissued common stock are therefore available for future issuances without stockholder approval and could be utilized
for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans.
The existence of authorized but unissued and unreserved common stock could render more difficult or discourage an attempt to obtain control
of us by means of a proxy contest, tender offer, merger or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Board of Directors</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide that the
number of directors will be fixed by the board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Nevada&nbsp;Anti-Takeover&nbsp;Provisions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Combinations With Interested Stockholders</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nevada law, NRS Sections 78.411
through 78.444, regulate business combinations with interested stockholders. Nevada law defines an interested stockholder as a beneficial
owner (directly or indirectly) of 10% or more of the voting power of the outstanding shares of the corporation. Pursuant to Sections NRS
78.411 through 78.444, combinations with an interested stockholder remain prohibited for two&nbsp;years after the person became an interested
stockholder unless (i)&nbsp;the transaction is approved by the board of directors or the holders of a majority of the outstanding shares
not beneficially owned by the interested party, or (ii)&nbsp;the interested stockholder satisfies certain fair value requirements. NRS
78.434 permits a Nevada corporation to opt-out&nbsp;of the statute with appropriate provisions in its articles of incorporation. We have
not opted out of these sections in our charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Acquisition of Controlling Interest</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NRS Sections 78.378 through
78.3793 regulates the acquisition of a controlling interest in an issuing corporation. An issuing corporation is defined as a Nevada corporation
with 200 or more stockholders of record, of which at least 100 stockholders have addresses of record in Nevada and does business in Nevada
directly or through an affiliated corporation. NRS Section&nbsp;78.379 provides that an acquiring person and those acting in association
with an acquiring person obtain only such voting rights in the control shares as are conferred by a resolution of the stockholders of
the corporation, approved at a special or annual meeting of the stockholders. Stockholders who vote against the voting rights have dissenters&rsquo;
rights in the event that the stockholders approve voting rights. NRS Section&nbsp;378 provides that a Nevada corporation&rsquo;s articles
of incorporation or bylaws may provide that these sections do not apply to the corporation. We have not opted out of these sections in
our charter and bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Removal of Directors; Vacancies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under NRS 78.335, one or more
of the incumbent directors may be removed from office by the vote of stockholders representing two-thirds&nbsp;or more of the voting power
of the issued and outstanding stock entitled to vote. Our bylaws provide that any newly created position on the board of directors that
results from an increase in the total number of directors and any vacancies on the board of directors will be filled only by the affirmative
vote of a majority of the remaining directors, even if less than a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>No Cumulative Voting</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The NRS does not permit stockholders
to cumulate their votes other than in the election of directors, and then only if expressly authorized by the corporation&rsquo;s articles
of incorporation. Our charter does not expressly authorize cumulative voting.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The combination of these provisions
will make it more difficult for our existing stockholders to replace our board of directors as well as for another party to obtain control
of us by replacing our board of directors. Because our board of directors has the power to retain and discharge our officers, these provisions
could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization
of undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences
that could impede the success of any attempt to change our control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These provisions are intended
to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage coercive
takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and
to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others
from making tender offers for our shares and may have the effect of delaying changes in our control or management. As a consequence, these
provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts.
We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent
of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals,
because negotiation of takeover proposals could result in an improvement of their terms.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Purchase Contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We may issue purchase
contracts for the purchase or sale of equity securities issued by us. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Each purchase contract
will entitle the holder thereof to purchase or sell, and obligate us to sell or purchase, on specified dates, such equity securities
issued by us at a specified purchase price, which may be based on a formula, as set forth in the applicable prospectus supplement. The
applicable prospectus supplement will also specify the methods by which the holders may purchase or sell such securities and any acceleration,
cancellation or termination provisions or other provisions relating to the settlement of a purchase contract.&nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Any purchase contracts
we issue will be physically settled by delivery of the securities. The purchase contracts may require the holders thereof to secure their
obligations in a specified manner to be described in the applicable prospectus supplement. Alternatively, purchase contracts may require
holders to satisfy their obligations thereunder when the purchase contracts are issued. Our obligation to settle such pre-paid purchase
contracts on the relevant settlement date may constitute indebtedness. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&nbsp;</b></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue warrants to purchase
our securities or other rights, including rights to receive payment in cash or securities based on the value, rate or price of one or
more specified commodities, currencies, securities or indices, or any combination of the foregoing. Warrants may be issued independently
or together with any other securities that may be sold by us pursuant to this prospectus or any combination of the foregoing and may be
attached to, or separate from, such securities. To the extent warrants that we issue are to be publicly-traded, each series of such warrants
will be issued under a separate warrant agreement to be entered into between us and a warrant agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will file as exhibits to
the registration statement of which this prospectus is a part, or will incorporate by reference from a current report on Form 8-K that
we file with the SEC, forms of the warrant and warrant agreement, if any. The prospectus supplement relating to any warrants that we may
offer will contain the specific terms of the warrants and a description of the material provisions of the applicable warrant agreement,
if any. These terms may include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the title of the warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the price or prices at which the warrants will be issued;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the designation, amount and terms of the securities or other rights for which the warrants are exercisable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the aggregate number of warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any provisions for adjustment of the number or amount of securities receivable upon exercise of the warrants or the exercise price of the warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the price or prices at which the securities or other rights purchasable upon exercise of the warrants may be purchased;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable, the date on and after which the warrants and the securities or other rights purchasable upon exercise of the warrants will be separately transferable;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a discussion of any material U.S. federal income tax considerations applicable to the exercise of the warrants;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the right to exercise the warrants will commence, and the date on which the right will expire;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the maximum or minimum number of warrants that may be exercised at any time;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">information with respect to book-entry procedures, if any; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercise of Warrants</I>.
Each warrant will entitle the holder of warrants to purchase the amount of securities or other rights, at the exercise price stated or
determinable in the prospectus supplement for the warrants. Warrants may be exercised at any time up to the close of business on the expiration
date shown in the applicable prospectus supplement, unless otherwise specified in such prospectus supplement. After the close of business
on the expiration date, if applicable, unexercised warrants will become void. Warrants may be exercised in the manner described in the
applicable prospectus supplement. When the warrant holder makes the payment and properly completes and signs the warrant certificate at
the corporate trust office of the warrant agent, if any, or any other office indicated in the prospectus supplement, we will, as soon
as possible, forward the securities or other rights that the warrant holder has purchased. If the warrant holder exercises less than all
of the warrants represented by the warrant certificate, we will issue a new warrant certificate for the remaining warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Currently Outstanding Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As of May 13, 2025, we
had the following warrants outstanding that were issued in connection with our initial public offering or in private placement transactions:
105,000 Representative&rsquo;s Warrants (as defined below), 3,067,482 Common Warrants (as defined below), 1,277,875 Placement Agent Warrants
(as defined below) and 2,699,797&nbsp;Inducement Warrants (as defined below). </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Representative&rsquo;s Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the initial
public offering, the Company issued to the representative of the underwriters and its designee (the &ldquo;Representative&rdquo;) warrants
(the &ldquo;Representative&rsquo;s Warrants&rdquo;) to purchase 105,000 shares of Class B Common Stock. In connection with the partial
exercise of the underwriters&rsquo; over-allotment option, the Company issued to the Representative and its designee additional Representative&rsquo;s
Warrants to purchase 2,128 shares of Class B Common Stock. The Representative&rsquo;s Warrants are exercisable at a per share exercise
price equal to $6.00 at any time and from time to time, in whole or in part, during the period commencing on May 21, 2024, and terminating
on November 21, 2028. Neither the Representative&rsquo;s Warrants nor any of the shares issued upon exercise of the Representative&rsquo;s
Warrants may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or
call transaction that would result in the effective economic disposition of such securities by any person, for a period of six (6) months
immediately following the commencement of sales of the initial public offering. The Representative&rsquo;s Warrants also provides for
one demand registration right of the shares underlying the Representative&rsquo;s Warrants at the Company&rsquo;s expense; one additional
demand registration at the warrant holders&rsquo; expense; and unlimited &ldquo;piggyback&rdquo; registration rights. The registration
rights will only be exercisable within a period of five years after November 16, 2023. The Representative&rsquo;s Warrants also contain
customary anti-dilution provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As of May 13, 2025, an
aggregate of 105,000 Representative&rsquo;s Warrants remain outstanding. </P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Common Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 3, 2024, the
Company issued warrants to purchase up to 15,555,557 shares of Class B Common Stock (the &ldquo;Common Warrants&rdquo;) to certain investors
in connection with the closing of a registered offering (the &ldquo;Offering&rdquo;), pursuant to the terms of a Securities Purchase Agreement,
dated August 29, 2024. The Common Warrants are exercisable immediately on the date of issuance at an exercise price of $1.35 per share
and will expire five years from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As of May 13, 2025, an
aggregate of 4,345,357 Common Warrants remain outstanding. </P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Placement Agent Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Rodman &amp; Renshaw LLC
(&ldquo;Rodman&rdquo;) acted as the exclusive placement agent (the &ldquo;Placement Agent&rdquo;) for the Company in connection with
the Offering. Pursuant to an engagement letter dated June 4, 2024, the Company issued to the Placement Agent warrants (the &ldquo;Placement
Agent Warrants&rdquo;) to purchase a number of shares of Class B Common Stock equal to 7.0% of the aggregate number of shares and pre-funded
warrants sold in the Offering. The Placement Agent Warrants have substantially the same terms as the Common Warrants, except that the
Placement Agent Warrants have an exercise price of 125% of the combined offering price per Share and accompanying Common Warrant and
have an expiration date of five years from the commencement of sales in the Offering. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Shares, Pre-Funded Warrants,
Common Warrants, Placement Agent Warrants and the shares of Class B common stock issuable upon exercise of the Pre-Funded Warrants, Common
Warrants, Placement Agent Warrants were offered and sold by the Company pursuant to the Prospectus, which formed a part of the Company&rsquo;s
registration statement on Form S-1 (File No. 333-281789), filed with the SEC on August 27, 2024 and subsequently declared effective on
August 29, 2024, and an additional registration statement on Form S-1MEF filed pursuant to Rule 462(b) under the Securities Act of 1933,
as amended, which became automatically effective on August 29, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As of May 13, 2025, an
aggregate of 1,277,875 Placement Agent Warrants in connection with the initial closing remain outstanding. </P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <i>Inducement Warrants</i> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> On February 10, 2025,
the Company entered into a warrant exercise inducement offer letter with Armistice Capital, LLC, a holder of its existing Common Warrants
exercisable for an aggregate of&nbsp;2,699,797&nbsp;shares of its Class B Common Stock (collectively, the &ldquo;Existing Warrants&rdquo;),
to exercise its Existing Warrants at the existing exercise price of $1.35&nbsp;per share, generating gross proceeds of approximately
$3,644,726&nbsp;before deducting financial advisory fees. In consideration for the immediate exercise of the Existing Warrants, the Company
issued to such holder&nbsp;2,699,797&nbsp;new warrants (the &ldquo;Inducement Warrants&rdquo;) with an exercise price of $4.00&nbsp;per
share, which are immediately exercisable and valid for five years from issuance (the &ldquo;Warrant Inducement&rdquo;). The shares of
Class B Common Stock underlying the Inducement Warrants are entitled to registration rights. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As of May 13, 2025, an
aggregate of 2,699,797&nbsp;Inducement Warrants remain outstanding. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In connection with the
Warrant Inducement, and pursuant to the engagement letter with Rodman, the Company issued to Rodman additional Placement Agent Warrants
to purchase an aggregate of&nbsp;188,986&nbsp;shares of Class B Common Stock at an exercise price of $5.00&nbsp;per share, which are
immediately exercisable and valid for&nbsp;five years&nbsp;from issuance. As of May 13, 2025, all such additional Placement Agent Warrants
remain outstanding. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Subscription Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue rights to purchase
our securities. The rights may or may not be transferable by the persons purchasing or receiving the rights. In connection with any rights
offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which
such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. In connection
with a rights offering to holders of our capital stock a prospectus supplement will be distributed to such holders on the record date
for receiving rights in the rights offering set by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will file as exhibits to
the registration statement of which this prospectus is a part, or will incorporate by reference from a current report on Form 8-K that
we file with the SEC, forms of the subscription rights, standby underwriting agreement or other agreements, if any. The prospectus supplement
relating to any rights that we offer will include specific terms relating to the offering, including, among other matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date of determining the security holders entitled to the rights distribution;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the aggregate number of rights issued and the aggregate amount of securities purchasable upon exercise of the rights;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the conditions to completion of the rights offering;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the right to exercise the rights will commence and the date on which the rights will expire; and</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any applicable federal income tax considerations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each right would entitle the
holder of the rights to purchase the principal amount of securities at the exercise price set forth in the applicable prospectus supplement.
Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus
supplement. After the close of business on the expiration date, all unexercised rights will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders may exercise rights
as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly executed
at the corporate trust office of the rights agent, if any, or any other office indicated in the prospectus supplement, we will, as soon
as practicable, forward the securities purchasable upon exercise of the rights. If less than all of the rights issued in any rights offering
are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters
or dealers or through a combination of such methods, including pursuant to standby underwriting arrangements, as described in the applicable
prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Depositary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>General. </I>We may offer
fractional shares of preferred stock, rather than full shares of preferred stock. If we decide to offer fractional shares of our preferred
stock, we will issue receipts for depositary shares. Each depositary share will represent a fraction of a share of a particular series
of our preferred stock, and the applicable prospectus supplement will indicate that fraction. The shares of preferred stock represented
by depositary shares will be deposited under a deposit agreement between us and a depositary that is a bank or trust company that meets
certain requirements and is selected by us. The depositary will be specified in the applicable prospectus supplement. Each owner of a
depositary share will be entitled to all of the rights and preferences of the preferred stock represented by the depositary share. The
depositary shares will be evidenced by depositary receipts issued pursuant to the deposit agreement. Depositary receipts will be distributed
to those persons purchasing the fractional shares of our preferred stock in accordance with the terms of the offering. We will file as
exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from a current report on Form
8-K that we file with the SEC, forms of the deposit agreement, form of certificate of designation of underlying preferred stock, form
of depositary receipts and any other related agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Dividends and Other Distributions</I><B>.</B>
The depositary will distribute all cash dividends or other cash distributions received by it in respect of the preferred stock to the
record holders of depositary shares relating to such preferred shares in proportion to the numbers of depositary shares held on the relevant
record date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of a distribution
other than in cash, the depositary will distribute securities or property received by it to the record holders of depositary shares in
proportion to the numbers of depositary shares held on the relevant record date, unless the depositary determines that it is not feasible
to make such distribution. In that case, the depositary may make the distribution by such method as it deems equitable and practicable.
One such possible method is for the depositary to sell the securities or property and then distribute the net proceeds from the sale as
provided in the case of a cash distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Redemption of Depositary
Shares</I><B>.</B> Whenever we redeem the preferred stock, the depositary will redeem a number of depositary shares representing the same
number of shares of preferred stock so redeemed. If fewer than all of the depositary shares are to be redeemed, the depositary shares
to be redeemed will be selected by lot, pro rata or by any other equitable method as the depositary may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Voting of Underlying Shares</I>.
Upon receipt of notice of any meeting at which the holders of our preferred stock of any series are entitled to vote, the depositary will
mail the information contained in the notice of the meeting to the record holders of the depositary shares relating to that series of
preferred stock. Each record holder of the depositary shares on the record date will be entitled to instruct the depositary as to the
exercise of the voting rights represented by the number of shares of preferred stock underlying the holder&rsquo;s depositary shares.
The depositary will endeavor, to the extent it is practical to do so, to vote the number of whole shares of preferred stock underlying
such depositary shares in accordance with such instructions. We will agree to take all action that the depositary may deem reasonably
necessary in order to enable the depositary to do so. To the extent the depositary does not receive specific instructions from the holders
of depositary shares relating to such preferred shares, it will abstain from voting such shares of preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Withdrawal of Shares</I>.
Upon surrender of depositary receipts representing any number of whole shares at the depositary&rsquo;s office, unless the related depositary
shares previously have been called for redemption, the holder of the depositary shares evidenced by the depositary receipts will be entitled
to delivery of the number of whole shares of the related series of preferred stock and all money and other property, if any, underlying
such depositary shares. However, once such an exchange is made, the preferred stock cannot thereafter be re-deposited in exchange for
depositary shares. Holders of depositary shares will be entitled to receive whole shares of the related series of preferred stock on the
basis set forth in the applicable prospectus supplement. If the depositary receipts delivered by the holder evidence a number of depositary
shares representing more than the number of whole shares of preferred stock of the related series to be withdrawn, the depositary will
deliver to the holder at the same time a new depositary receipt evidencing the excess number of depositary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Amendment and Termination
of Depositary Agreement</I><B>.</B> The form of depositary receipt evidencing the depositary shares and any provision of the applicable
depositary agreement may at any time be amended by agreement between us and the depositary. We may, with the consent of the depositary,
amend the depositary agreement from time to time in any manner that we desire. However, if the amendment would materially and adversely
alter the rights of the existing holders of depositary shares, the amendment would need to be approved by the holders of at least a majority
of the depositary shares then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The depositary agreement may be terminated by us
or the depositary if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all outstanding depositary shares have been redeemed; or</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there has been a final distribution in respect of the shares of preferred stock of the applicable series in connection with our liquidation, dissolution or winding up and such distribution has been made to the holders of depositary receipts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Resignation and Removal
of Depositary.</I> The depositary may resign at any time by delivering to us notice of its election to do so. We may remove a depositary
at any time. Any resignation or removal will take effect upon the appointment of a successor depositary and its acceptance of appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Charges of Depositary.</I>
We will pay all transfer and other taxes and governmental charges arising solely from the existence of any depositary arrangements. We
will pay all charges of each depositary in connection with the initial deposit of the preferred shares of any series, the initial issuance
of the depositary shares, any redemption of such preferred shares and any withdrawals of such preferred shares by holders of depositary
shares. Holders of depositary shares will be required to pay any other transfer taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Notices. </I>Each depositary
will forward to the holders of the applicable depositary shares all notices, reports and communications from us which are delivered to
such depositary and which we are required to furnish the holders of the preferred stock represented by such depositary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Miscellaneous</I>. The
depositary agreement may contain provisions that limit our liability and the liability of the depositary to the holders of depositary
shares. Both the depositary and we are also entitled to an indemnity from the holders of the depositary shares prior to bringing, or defending
against, any legal proceeding. We or any depositary may rely upon written advice of counsel or accountants, or information provided by
persons presenting preferred shares for deposit, holders of depositary shares or other persons believed by us to be competent and on documents
believed by us or them to be genuine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this prospectus,
the term &ldquo;debt securities&rdquo; means the debentures, notes, bonds and other evidences of indebtedness that we may issue from time
to time. The debt securities will either be senior debt securities, senior subordinated debt or subordinated debt securities. We may also
issue convertible debt securities. Debt securities may be issued under an indenture (which we refer to herein as an Indenture), which
are contracts entered into between us and a trustee to be named therein. The Indenture has been filed as an exhibit to the registration
statement of which this prospectus forms a part. We may issue debt securities and incur additional indebtedness other than through the
offering of debt securities pursuant to this prospectus. It is likely that convertible debt securities will not be issued under an Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The debt securities may be
fully and unconditionally guaranteed on a secured or unsecured senior or subordinated basis by one or more guarantors, if any. The obligations
of any guarantor under its guarantee will be limited as necessary to prevent that guarantee from constituting a fraudulent conveyance
under applicable law. In the event that any series of debt securities will be subordinated to other indebtedness that we have outstanding
or may incur, the terms of the subordination will be set forth in the prospectus supplement relating to the subordinated debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
from time to time in one or more series, in each case with the same or various maturities, at par or at a discount. Unless indicated in
a prospectus supplement, we may issue additional debt securities of a particular series without the consent of the holders of the debt
securities of such series outstanding at the time of the issuance. Any such additional debt securities, together with all other outstanding
debt securities of that series, will constitute a single series of debt securities under the applicable Indenture and will be equal in
ranking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Should an Indenture relate
to unsecured indebtedness, in the event of a bankruptcy or other liquidation event involving a distribution of assets to satisfy our outstanding
indebtedness or an event of default under a loan agreement relating to secured indebtedness of our company or its subsidiaries, the holders
of such secured indebtedness, if any, would be entitled to receive payment of principal and interest prior to payments on the unsecured
indebtedness issued under an Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each prospectus supplement
will describe the terms relating to the specific series of debt securities. These terms will include some or all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the title of debt securities and whether the debt securities are senior or subordinated;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any limit on the aggregate principal amount of debt securities of such series;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the percentage of the principal amount at which the debt securities of any series will be issued;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ability to issue additional debt securities of the same series;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the purchase price for the debt securities and the denominations of the debt securities;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the specific designation of the series of debt securities being offered;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the maturity date or dates of the debt securities and the date or dates upon which the debt securities are payable and the rate or rates at which the debt securities of the series shall bear interest, if any, which may be fixed or variable, or the method by which such rate shall be determined;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the basis for calculating interest;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date or dates from which any interest will accrue or the method by which such date or dates will be determined;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the duration of any deferral period, including the period during which interest payment periods may be extended;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether the amount of payments of principal of (and premium, if any) or interest on the debt securities may be determined with reference to any index, formula or other method, such as one or more currencies, commodities, equity indices or other indices, and the manner of determining the amount of such payments;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the dates on which we will pay interest on the debt securities and the regular record date for determining who is entitled to the interest payable on any interest payment date;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the place or places where the principal of (and premium, if any) and interest on the debt securities will be payable, where any securities may be surrendered for registration of transfer, exchange or conversion, as applicable, and notices and demands may be delivered to or upon us pursuant to the applicable Indenture;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the rate or rates of amortization of the debt securities;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any terms for the attachment to the debt securities of warrants, options or other rights to purchase or sell our securities;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the debt securities will be secured by any collateral and, if so, a general description of the collateral and the terms and provisions of such collateral security, pledge or other agreements;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if we possess the option to do so, the periods within which and the prices at which we may redeem the debt securities, in whole or in part, pursuant to optional redemption provisions, and the other terms and conditions of any such provisions;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our obligation or discretion, if any, to redeem, repay or purchase debt securities by making periodic payments to a sinking fund or through an analogous provision or at the option of holders of the debt securities, and the period or periods within which and the price or prices at which we will redeem, repay or purchase the debt securities, in whole or in part, pursuant to such obligation, and the other terms and conditions of such obligation;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms and conditions, if any, regarding the option or mandatory conversion or exchange of debt securities;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the period or periods within which, the price or prices at which and the terms and conditions upon which any debt securities of the series may be redeemed, in whole or in part at our option and, if other than by a board resolution, the manner in which any election by us to redeem the debt securities shall be evidenced;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any restriction or condition on the transferability of the debt securities of a particular series;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the portion, or methods of determining the portion, of the principal amount of the debt securities which we must pay upon the acceleration of the maturity of the debt securities in connection with any event of default;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the currency or currencies in which the debt securities will be denominated and in which principal, any premium and any interest will or may be payable or a description of any units based on or relating to a currency or currencies in which the debt securities will be denominated;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provisions, if any, granting special rights to holders of the debt securities upon the occurrence of specified events;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any deletions from, modifications of or additions to the events of default or our covenants with respect to the applicable series of debt securities, and whether or not such events of default or covenants are consistent with those contained in the applicable Indenture;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any limitation on our ability to incur debt, redeem stock, sell our assets or other restrictions;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the application, if any, of the terms of the applicable Indenture relating to defeasance and covenant defeasance (which terms are described below) to the debt securities;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">what subordination provisions will apply to the debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms, if any, upon which the holders may convert or exchange the debt securities into or for our securities or property;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether we are issuing the debt securities in whole or in part in global form;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any change in the right of the trustee or the requisite holders of debt securities to declare the principal amount thereof due and payable because of an event of default;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the depositary for global or certificated debt securities, if any;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any material federal income tax consequences applicable to the debt securities, including any debt securities denominated and made payable, as described in the prospectus supplements, in foreign currencies, or units based on or related to foreign currencies;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any right we may have to satisfy, discharge and defease our obligations under the debt securities, or terminate or eliminate restrictive covenants or events of default in the Indentures, by depositing money or U.S. government obligations with the trustee of the Indentures;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the names of any trustees, depositories, authenticating or paying agents, transfer agents or registrars or other agents with respect to the debt securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to whom any interest on any debt security shall be payable, if other than the person in whose name the security is registered, on the record date for such interest, the extent to which, or the manner in which, any interest payable on a temporary global debt security will be paid;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the principal of or any premium or interest on any debt securities is to be payable in one or more currencies or currency units other than as stated, the currency, currencies or currency units in which it shall be paid and the periods within and terms and conditions upon which such election is to be made and the amounts payable (or the manner in which such amount shall be determined);</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the portion of the principal amount of any debt securities which shall be payable upon declaration of acceleration of the maturity of the debt securities pursuant to the applicable Indenture;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the principal amount payable at the stated maturity of any debt security of the series will not be determinable as of any one or more dates prior to the stated maturity, the amount which shall be deemed to be the principal amount of such debt securities as of any such date for any purpose, including the principal amount thereof which shall be due and payable upon any maturity other than the stated maturity or which shall be deemed to be outstanding as of any date prior to the stated maturity (or, in any such case, the manner in which such amount deemed to be the principal amount shall be determined); and</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other specific terms of the debt securities, including any modifications to the events of default under the debt securities and any other terms which may be required by or advisable under applicable laws or regulations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise specified
in the applicable prospectus supplement, we do not anticipate the debt securities will be listed on any securities exchange. Holders of
the debt securities may present registered debt securities for exchange or transfer in the manner described in the applicable prospectus
supplement. Except as limited by the applicable Indenture, we will provide these services without charge, other than any tax or other
governmental charge payable in connection with the exchange or transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Debt securities may bear interest
at a fixed rate or a variable rate as specified in the prospectus supplement. In addition, if specified in the prospectus supplement,
we may sell debt securities bearing no interest or interest at a rate that at the time of issuance is below the prevailing market rate,
or at a discount below their stated principal amount. We will describe in the applicable prospectus supplement any special federal income
tax considerations applicable to these discounted debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
with the principal amount payable on any principal payment date, or the amount of interest payable on any interest payment date, to be
determined by referring to one or more currency exchange rates, commodity prices, equity indices or other factors. Holders of such debt
securities may receive a principal amount on any principal payment date, or interest payments on any interest payment date, that are greater
or less than the amount of principal or interest otherwise payable on such dates, depending upon the value on such dates of applicable
currency, commodity, equity index or other factors. The applicable prospectus supplement will contain information as to how we will determine
the amount of principal or interest payable on any date, as well as the currencies, commodities, equity indices or other factors to which
the amount payable on that date relates and certain additional tax considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue units consisting
of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each series of
units by unit certificates that we may issue under a separate agreement. We may enter into unit agreements with a unit agent. Each unit
agent, if any, may be a bank or trust company that we select. We will indicate the name and address of the unit agent, if any, in the
applicable prospectus supplement relating to a particular series of units. Specific unit agreements, if any, will contain additional important
terms and provisions. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate
by reference from a current report that we file with the SEC, the form of unit and the form of each unit agreement, if any, relating to
units offered under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we offer any units, certain
terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the following,
as applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the title of the series of units;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification and description of the separate constituent securities comprising the units;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the price or prices at which the units will be issued;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date, if any, on and after which the constituent securities comprising the units will be separately transferable;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a discussion of certain United States federal income tax considerations applicable to the units; and</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other material terms of the units and their constituent securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>FORMS OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each security may be represented
either by a certificate issued in definitive form to a particular investor or by one or more global securities representing the entire
issuance of securities. Certificated securities in definitive form and global securities will be issued in registered form. Definitive
securities name you or your nominee as the owner of the security, and in order to transfer or exchange these securities or to receive
payments other than interest or other interim payments, you or your nominee must physically deliver the securities to the trustee, registrar,
paying agent or other agent, as applicable. Global securities name a depositary or its nominee as the owner of the debt securities, warrants
or units represented by these global securities. The depositary maintains a computerized system that will reflect each investor&rsquo;s
beneficial ownership of the securities through an account maintained by the investor with its broker/dealer, bank, trust company or other
representative, as we explain more fully below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Registered Global Securities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue the securities
in the form of one or more fully registered global securities that will be deposited with a depositary or its nominee identified in the
applicable prospectus supplement and registered in the name of that depositary or nominee. In those cases, one or more registered global
securities will be issued in a denomination or aggregate denominations equal to the portion of the aggregate principal or face amount
of the securities to be represented by registered global securities. Unless and until it is exchanged in whole for securities in definitive
registered form, a registered global security may not be transferred except as a whole by and among the depositary for the registered
global security, the nominees of the depositary or any successors of the depositary or those nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The specific terms of the
depositary arrangement with respect to any securities to be represented by a registered global security will be described in the prospectus
supplement relating to those securities. We anticipate that the following provisions will apply to all depositary arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ownership of beneficial interests
in a registered global security will be limited to persons, called participants, that have accounts with the depositary or persons that
may hold interests through participants. Upon the issuance of a registered global security, the depositary will credit, on its book-entry
registration and transfer system, the participants&rsquo; accounts with the respective principal or face amounts of the securities beneficially
owned by the participants. Any dealers, underwriters or agents participating in the distribution of the securities will designate the
accounts to be credited. Ownership of beneficial interests in a registered global security will be shown on, and the transfer of ownership
interests will be effected only through, records maintained by the depositary, with respect to interests of participants, and on the records
of participants, with respect to interests of persons holding through participants. The laws of some states may require that some purchasers
of securities take physical delivery of these securities in definitive form. These laws may impair your ability to own, transfer or pledge
beneficial interests in registered global securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">So long as the depositary,
or its nominee, is the registered owner of a registered global security, that depositary or its nominee, as the case may be, will be considered
the sole owner or holder of the securities represented by the registered global security for all purposes under the applicable indenture,
warrant agreement or unit agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as described below,
owners of beneficial interests in a registered global security will not be entitled to have the securities represented by the registered
global security registered in their names, will not receive or be entitled to receive physical delivery of the securities in definitive
form and will not be considered the owners or holders of the securities under the applicable indenture, warrant agreement or unit agreement.
Accordingly, each person owning a beneficial interest in a registered global security must rely on the procedures of the depositary for
that registered global security and, if that person is not a participant, on the procedures of the participant through which the person
owns its interest, to exercise any rights of a holder under the applicable indenture, warrant agreement or unit agreement. We understand
that under existing industry practices, if we request any action of holders or if an owner of a beneficial interest in a registered global
security desires to give or take any action that a holder is entitled to give or take under the applicable indenture, warrant agreement
or unit agreement, the depositary for the registered global security would authorize the participants holding the relevant beneficial
interests to give or take that action, and the participants would authorize beneficial owners owning through them to give or take that
action or would otherwise act upon the instructions of beneficial owners holding through them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payments to holders with respect
to securities represented by a registered global security registered in the name of a depositary or its nominee will be made to the depositary
or its nominee, as the case may be, as the registered owner of the registered global security. None of the Company, the trustees, the
warrant agents, the unit agents or any other agent of the Company, agent of the trustees, the warrant agents or unit agents will have
any responsibility or liability for any aspect of the records relating to payments made on account of beneficial ownership interests in
the registered global security or for maintaining, supervising or reviewing any records relating to those beneficial ownership interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect that the depositary
for any of the securities represented by a registered global security, upon receipt of any payment of principal, premium, interest or
other payment or distribution to holders of that registered global security, will immediately credit participants&rsquo; accounts in amounts
proportionate to their respective beneficial interests in that registered global security as shown on the records of the depositary. We
also expect that payments by participants to owners of beneficial interests in a registered global security held through participants
will be governed by standing customer instructions and customary practices, as is now the case with the securities held for the accounts
of customers or registered in &ldquo;street name,&rdquo; and will be the responsibility of those participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the depositary for any
of these securities represented by a registered global security is at any time unwilling or unable to continue as depositary or ceases
to be a clearing agency registered under the Exchange Act and a successor depositary registered as a clearing agency under the Exchange
Act is not appointed by us within 90 days, we will issue securities in definitive form in exchange for the registered global security
that had been held by the depositary. Any securities issued in definitive form in exchange for a registered global security will be registered
in the name or names that the depositary gives to the relevant trustee, warrant agent, unit agent or other relevant agent of ours or theirs.
It is expected that the depositary&rsquo;s instructions will be based upon directions received by the depositary from participants with
respect to ownership of beneficial interests in the registered global security that had been held by the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise
indicated in the applicable prospectus supplement, the validity of the securities offered by this prospectus will be passed upon for
us by Ellenoff Grossman &amp; Schole LLP, New York, New York and, with respect to certain matters of Nevada law, Fennemore Craig,
P.C., Las Vegas, Nevada. If legal matters in connection with offerings made by this prospectus are passed on by counsel for the
underwriters, dealers or agents, if any, that counsel will be named in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Our audited consolidated
financial statements as of September&nbsp;30, 2024 and 2023 and for the two&nbsp;years then ended have been incorporated by reference
into this prospectus and the registration statement of which it forms a part in reliance upon the report of Bush&nbsp;&amp; Associates
CPA, independent registered public accounting firm and upon the report of such firm given upon the authority of said firm as experts
in accounting and auditing. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We file annual, quarter and
periodic reports, proxy statements and other information with the SEC using its EDGAR system. The SEC maintains a web site that contains
reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address
of such site is http//www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_012"></A>INCORPORATION
OF DOCUMENTS BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We are &ldquo;incorporating
by reference&rdquo; in this prospectus certain documents we file with the SEC, which means that we can disclose important information
to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this
prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will
automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports
that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the
old information. All filings we file pursuant to the Exchange Act after the date of the registration statement of which this prospectus
forms a part and prior to effectiveness of the Registration Statement
shall be deemed to be incorporated by reference into the prospectus. We have filed or may file the following documents with the SEC and
they are incorporated herein by reference as of their respective dates of filing. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"> 1. </td><td style="text-align: justify"> Our Annual Report on <a href="http://www.sec.gov/Archives/edgar/data/1963685/000121390025003458/ea0226831-10k_richtech.htm">Form
                                            10-K</a> for the year ended September 30, 2024, filed with the SEC on January 14, 2025, as
                                            amended on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1963685/000121390025011327/ea0230367-10ka1_richtech.htm">Form
                                            10-K/A</a> on February 7, 2025 and further amended on March 4, 2025; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"> 2. </td><td style="text-align: justify"> Our Quarterly Reports on Form
                                            10-Q for the quarterly period ended <A HREF="http://www.sec.gov/Archives/edgar/data/1963685/000121390025014251/ea0230932-10q_richtech.htm">December 31, 2024</A> and March 31, 2025, filed with the SEC on February
                                            14, 2025 and May 14, 2025, respectively; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"> 3. </td><td style="text-align: justify"> Our Current Reports on Form 8-K filed
                                            with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390024089677/ea0218284-8k_richtech.htm">October 22, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390024092915/ea0219333-8k_richtech.htm">October 31, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1963685/000121390025011887/ea0230588-8k_richtech.htm">February
                                            11, 2025</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/1963685/000121390025031633/ea0238240-8k_richtech.htm">April
                                            14, 2025</A>, respectively.&nbsp; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All documents that we filed
with the SEC pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act subsequent to the date of this registration statement
and prior to the filing of a post-effective amendment to this registration statement that indicates that all securities offered under
this prospectus have been sold, or that deregisters all securities then remaining unsold, will be deemed to be incorporated in this registration
statement by reference and to be a part hereof from the date of filing of such documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any statement contained in
a document incorporated or deemed to be incorporated by reference in this prospectus shall be deemed modified, superseded or replaced
for purposes of this prospectus to the extent that a statement contained in this prospectus, or in any subsequently filed document that
also is deemed to be incorporated by reference in this prospectus, modifies, supersedes or replaces such statement. Any statement so modified,
superseded or replaced shall not be deemed, except as so modified, superseded or replaced, to constitute a part of this prospectus. None
of the information that we disclose under Items 2.02 or 7.01 of any Current Report on Form 8-K or any corresponding information, either
furnished under Item 9.01 or included as an exhibit therein, that we may from time to time furnish to the SEC will be incorporated by
reference into, or otherwise included in, this prospectus, except as otherwise expressly set forth in the relevant document. Subject to
the foregoing, all information appearing in this prospectus is qualified in its entirety by the information appearing in the documents
incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may request, orally or
in writing, a copy of these documents, which will be provided to you at no cost (other than exhibits, unless such exhibits are specifically
incorporate by reference), by contacting General Counsel, c/o Richtech Robotics Inc., at 4175 Cameron St Ste 1, Las Vegas, NV 89103. Our
telephone number is (866) 236-3835. Information about us is also available at our website at <I>www.richtechrobotics.com</I>. However,
the information in our website is not a part of this prospectus and is not incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <font style="color: Red"><b>The information
in this prospectus is not complete and may be changed. We may not sell the securities until the Registration Statement filed with the
Securities and Exchange Commission, of which this prospectus is a part, is effective. This prospectus is not an offer to sell these securities
and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</b></font> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="color: Red"><B>SUBJECT TO COMPLETION,
DATED MAY 14, 2025</B></FONT> </P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <b>Prospectus</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <b>RICHTECH ROBOTICS INC.</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <b>2,699,797 SHARES OF CLASS B COMMON STOCK</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to this prospectus,
the selling stockholder identified herein (the &ldquo;Selling Stockholder&rdquo;) is offering on a resale basis an aggregate of 2,699,797
shares (&ldquo;Shares&rdquo;) of Class B common stock, par value $0.0001 per share (the &ldquo;Class B Common Stock&rdquo; or the &ldquo;Common
Stock&rdquo;), of Richtech Robotics Inc. (&ldquo;Richtech,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;),
representing shares of Class B Common Stock held directly or indirectly by the Selling Stockholder. We will not receive any proceeds
from the sale of the Shares by the Selling Stockholder. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The Selling Stockholder
may sell or otherwise dispose of the Shares in a number of different ways and at varying prices. The Selling Stockholder may sell any,
all or none of the securities offered by this prospectus, and we do not know when or in what amount the Selling Stockholder may sell
its Shares hereunder following the effective date of the registration statement of which this prospectus forms a part. We provide more
information about how the Selling Stockholder may sell or otherwise dispose of the Shares in the section entitled &ldquo;Plan of Distribution&rdquo;
on page 5. Discounts, concessions, commissions and similar selling expenses attributable to the sale of the Shares will be borne
by the Selling Stockholder. We will pay all expenses (other than discounts, concessions, commissions and similar selling expenses) relating
to the registration of the Shares with the Securities and Exchange Commission (&ldquo;SEC&rdquo;). </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Our Class B Common Stock
is listed on The Capital Market of The Nasdaq Stock Market LLC (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;RR.&rdquo; The last reported
sale price of our Class B Common Stock on May 13, 2025 was $2.27 per share. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <b>Investing in our securities
involves certain risks. See &ldquo;Risk Factors&rdquo; beginning on page 2</b>&nbsp; <b>and the risk factors in our most recent Annual
Report on Form 10-K/A, which is incorporated by reference herein, as well as in any other recently filed quarterly or current reports
and, if any, in the relevant prospectus supplement. We urge you to carefully read this prospectus and any applicable prospectus supplement,
together with the documents we incorporate by reference, describing the terms of these securities before investing.</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <b>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> The date of this Prospectus is _____________,
2025. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: center"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <b>TABLE OF CONTENTS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top; width: 92%"> &nbsp; </td>
    <td style="width: 8%; border-bottom: black 1.5pt solid; text-align: center"> <font style="font-size: 10pt"><b>Page</b></font> </td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td> <font style="font-size: 10pt"><a href="#s_001">About This Prospectus</a></font> </td>
    <td style="text-align: center"> ii </td></tr>
  <tr style="background-color: White">
    <td> <font style="font-size: 10pt"><a href="#s_002">Cautionary Statement Regarding Forward-Looking Statements</a></font> </td>
    <td style="vertical-align: top; text-align: center"> iii </td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td> <font style="font-size: 10pt"><a href="#s_003">Prospectus Summary</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 1 </td></tr>
  <tr style="background-color: White">
    <td> <font style="font-size: 10pt"><a href="#s_004">Risk Factors</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 2 </td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td> <font style="font-size: 10pt"><a href="#s_005">Use of Proceeds</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 3 </td></tr>
  <tr style="background-color: White">
    <td> <font style="font-size: 10pt"><a href="#s_006">Selling Stockholders</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 4 </td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td> <font style="font-size: 10pt"><a href="#s_007">Plan of Distribution</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 5 </td></tr>
  <tr style="background-color: White">
    <td> <font style="font-size: 10pt"><a href="#s_008">Legal Matters</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 7 </td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td> <font style="font-size: 10pt"><a href="#s_009">Experts</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 7 </td></tr>
  <tr style="background-color: White">
    <td> <font style="font-size: 10pt"><a href="#s_010">Where You Can Find Additional Information</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 7 </td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td> <font style="font-size: 10pt"><a href="#s_011">Incorporation of Documents By Reference</a></font> </td>
    <td style="vertical-align: top; text-align: center"> 8 </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_001"></a> <b>ABOUT THIS PROSPECTUS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> This prospectus is part
of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or SEC, utilizing a &ldquo;shelf&rdquo;
registration process. Under this shelf registration process, the Selling Stockholder may, from time to time, offer and sell the securities
described in this prospectus in one or more offerings. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> This prospectus provides
you with a general description of the of the Shares that the Selling Stockholder may offer. Each time the Selling Stockholder sells the
Shares, under this prospectus, to the extent necessary and required by law, we will provide a prospectus supplement to this prospectus
that will contain more specific information about the terms of that offering. We may also authorize one or more free writing prospectuses
to be provided to you that may contain material information relating to this offering. The prospectus supplement and any related free
writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this
prospectus or in the documents that we have incorporated by reference into this prospectus. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> We urge you to read carefully
this prospectus, any applicable prospectus supplement and any free writing prospectuses we have authorized for use in connection with
this offering, together with the information incorporated herein by reference as described under the heading &ldquo;Incorporation of
Documents by Reference,&rdquo; before investing in any of the securities being offered. You should rely only on the information contained
in, or incorporated by reference into, this prospectus and any applicable prospectus supplement, along with the information contained
in any free writing prospectuses we have authorized for use in connection with a specific offering. Neither we, nor the Selling Stockholder,
have authorized anyone to provide you with different or additional information. We take no responsibility for, and can provide no assurance
as to the reliability of, any other information that others may give you. The Selling Stockholder is offering to sell, and seeking offers
to buy, our securities only in jurisdictions where it is lawful to do so. This prospectus and any accompanying prospectus supplement
do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which
they relate, nor do this prospectus or any applicable supplement to this prospectus constitute an offer to sell or the solicitation of
an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The information appearing
in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the date on the
front of the document and any information we have incorporated by reference is accurate only as of the date of the document incorporated
by reference, regardless of the time of delivery of this prospectus, any applicable prospectus supplement or any related free writing
prospectus, or any sale of a security. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> This prospectus contains
summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for
complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred
to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this
prospectus is a part, and you may obtain copies of those documents as described below under the section entitled &ldquo;Where You Can
Find Additional Information.&rdquo; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> This prospectus contains,
or incorporates by reference, trademarks, tradenames, service marks and service names of Richtech and its subsidiaries.&nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_002"></a> <b>CAUTIONARY NOTE REGARDING FORWARD LOOKING
STATEMENTS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> This prospectus and the
documents incorporated by reference herein contain or may contain forward looking statements that involve risks and uncertainties. All
statements other than statements of historical fact contained in this prospectus and the documents incorporated by reference herein,
including statements regarding future events, our future financial performance, business strategy, and plans and objectives of management
for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including
&ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;can,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimates,&rdquo;
&ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;plans,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;should,&rdquo; or &ldquo;will&rdquo; or the negative of these terms or other comparable terminology. The following factors among
others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking
statements: </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Our ability to secure raw materials and components to manufacture
    sufficient quantities of robots to match demand;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Our ability to secure enterprise clients and deals in the face of
    growing competition;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Assumptions around the speed of robotic adoption in service environments;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Assumptions relating to the size of the market for our products
    and services;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Unanticipated regulations of robots and automation that add barriers
    to adoption and have a negative effect on our business;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Our ability to obtain and maintain intellectual property protection
    for our products;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Our estimates of expenses, future revenue, capital requirements
    and our needs for, or ability to obtain, additional financing;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">The ability to attract or maintain a qualified workforce;</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">The possibility that we may be adversely affected by other economic,
    business, and/or competitive factors; and</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"> &nbsp; </td>
    <td style="width: 24px; font-size: 10pt"> <font style="font-size: 10pt">&#9679;</font> </td>
    <td style="font-size: 10pt; text-align: justify"> <font style="font-size: 10pt">Other risks and uncertainties described under the
    section titled &ldquo;Risk Factors&rdquo; in this prospectus.</font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Although we do not make
forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements
are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under &ldquo;Risk
Factors&rdquo; or elsewhere in this prospectus and the documents incorporated by reference herein, which may cause our or our industry&rsquo;s
actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Moreover, we
operate in a highly regulated, very competitive, and rapidly changing environment. New risks emerge from time to time and it is not possible
for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or
combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements.&nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We have based these forward-looking
statements largely on our current expectations and projections about future events and financial trends that we believe may affect our
financial condition, results of operations, business strategy, short term and long term business operations, and financial needs. These
forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from
those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited
to, those discussed in this prospectus, and in particular, the risks discussed below and under the heading &ldquo;Risk Factors&rdquo;
and those discussed in other documents we file with the SEC. The following discussion should be read in conjunction with the consolidated
financial statements for the fiscal years ended September 30, 2024 and 2023 and notes incorporated by reference herein. We undertake
no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law.
In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus may
not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statement. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> You should not place undue
reliance on any forward-looking statement, each of which applies only as of the date of this prospectus. Except as required by law, we
undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this prospectus to conform
our statements to actual results or changed expectations. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Any forward-looking statement
you read in this prospectus, any prospectus supplement or any document incorporated by reference reflects our current views with respect
to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, operating results,
growth strategy and liquidity. You should not place undue reliance on these forward-looking statements because such statements speak
only as to the date when made. We assume no obligation to publicly update or revise these forward-looking statements for any reason,
or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new
information becomes available in the future, except as otherwise required by applicable law. You are advised, however, to consult any
further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the SEC. You should understand
that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete
set of all potential risks or uncertainties. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<div style="padding: 5.4pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_003"></a> <b>PROSPECTUS SUMMARY</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <i>This summary highlights
selected information contained elsewhere in this prospectus. This summary does not contain all the information that you should consider
before investing in our Company. You should carefully read the entire prospectus, including all documents incorporated by reference herein.
In particular, attention should be directed to our &ldquo;Risk Factors,&rdquo; &ldquo;Information With Respect to the Company,&rdquo;
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and the financial statements
and related notes thereto contained herein or otherwise incorporated by reference hereto, before making an investment decision.</i> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As used herein, and any
amendment or supplement hereto, unless otherwise indicated, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; the &ldquo;Company,&rdquo;
or &ldquo;Richtech&rdquo; means Richtech Robotics Inc., including its consolidated subsidiaries. Unless otherwise indicated, all references
in this prospectus to &ldquo;dollars&rdquo; or &ldquo;$&rdquo; refer to US dollars.&nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b>Overview</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We are a developer of
advanced robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing
unprecedented labor shortages. With a global R&amp;D team based out of China and the United States, we design, manufacture and sell robots
to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Our robots perform a variety
of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food
preparation. We design our robots to be friendly, customizable to client environments, and extremely reliable. For example, our food
service delivery robots typically make over 1000 deliveries every month in busy environments, while our medical robots are utilized for
tasks such as delivering medications and supplies in hospitals, enhancing operational efficiency. Our current customer base includes
major hotel brands, national chain restaurants, leading senior care facilities, and top casino management companies, and prominent healthcare
institutions. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Our mission is to integrate
robotics and automation into our everyday lives. We envision ourselves becoming the first robotics &ldquo;Super-operator,&rdquo; where
thousands of our robots are deployed out in the field and managed by Richtech&rsquo;s AI Cloud Platform (ACP). As a Super-operator, our
robotic fleet will be performing a wide variety of tasks within a business, from completing deliveries and scrubbing floors to cooking
noodles, preparing drinks, and supporting logistics in hospitals. Our ACP platform will allow businesses to plug in their robots and
immediately leverage an immense amount of data to optimize workflows, lower management complexity, and minimize labor dependency. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b>Warrant Inducement</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> On February 10, 2025,
the Company entered into a warrant exercise inducement offer letter with a holder of its existing Common Warrants exercisable for an
aggregate of&nbsp;2,699,797&nbsp;shares of its Class B Common Stock (collectively, the &ldquo;Existing Warrants&rdquo;), to exercise
its Existing Warrants at the existing exercise price of $1.35&nbsp;per share, generating gross proceeds of approximately $3,644,726&nbsp;before
deducting financial advisory fees. In consideration for the immediate exercise of the Existing Warrants, the Company issued to such holder&nbsp;2,699,797&nbsp;new
warrants (the &ldquo;Inducement Warrants&rdquo;) with an exercise price of $4.00&nbsp;per share, which are immediately exercisable and
valid for five years from issuance (the &ldquo;Warrant Inducement&rdquo;). The Shares underlying the Inducement Warrants are entitled
to registration rights. This registration statement is being filed in order to satisfy the Company&rsquo;s obligation with respect to
such registration rights. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b>Corporate Information</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Our principal executive
offices are located at 4175 Cameron St Ste 1, Las Vegas, NV 89103, and our telephone number is (866) 236-3835. Our corporate website
address is <i>www.richtechrobotics.com</i>. The information contained on or accessible through our website is not a part of, and is not
incorporated by reference into, this prospectus. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 40; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_004"></a> <b>RISK FACTORS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Investing in our securities
involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risk factors we
describe in any prospectus supplement and in any related free writing prospectus for a specific offering of securities, as well as those
incorporated by reference into this prospectus and any prospectus supplement. You should also carefully consider other information contained
and incorporated by reference in this prospectus and any applicable prospectus supplement, including our financial statements and the
related notes thereto incorporated by reference in this prospectus. The risks and uncertainties described in the applicable prospectus
supplement and our other filings with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) incorporated by reference herein
are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently consider immaterial
may also adversely affect us. If any of the described risks occur, our business, financial condition or results of operations could be
materially harmed. In such case, the value of our securities could decline and you may lose all or part of your investment. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_005"></a> <b>USE OF PROCEEDS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We are not selling any
securities under this prospectus and, other than receipt of the exercise price of the warrants, we will not receive any proceeds from
the sale of the Shares covered hereby. The net proceeds from the sale of the Shares offered by this prospectus will be received by the
Selling Stockholder. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Subject to limited exceptions,
the Selling Stockholder will pay any underwriting discounts and commissions and expenses incurred by the Selling Stockholder for brokerage,
accounting, tax or legal services or any other expenses incurred by the Selling Stockholder in disposing of any of the Shares being sold.
We will bear the costs, fees and expenses incurred in effecting the registration of the Shares covered by this prospectus, including
all registration and filing fees, Nasdaq listing fees, and fees and expenses of our counsel and our independent registered public accounting
firm. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_006"></a> <b>SELLING STOCKHOLDERS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> This prospectus covers
the possible resale or other disposition from time to time by the Selling Stockholder identified in the table below of up to an aggregate
of 2,699,797 shares of our Class B Common Stock, which represent the Shares issuable upon conversion of the Inducement Warrants issued
to the Selling Stockholder in the Warrant Inducement. The Selling Stockholder may from time to time offer and sell any or all of the
Shares set forth below pursuant to this prospectus and any accompanying prospectus supplement. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We are registering such
Shares to permit the Selling Stockholders and its pledgees, donees, transferees or other successors-in-interest that receive their Shares
after the date of this prospectus to resell or otherwise dispose of the Shares in the manner contemplated under &ldquo;Plan of Distribution&rdquo;
herein. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Except as otherwise disclosed
herein, the Selling Stockholder does not have, and within the past three years have not had, any position, office or other material relationship
with us. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The Selling Stockholder
may sell some, all or none of their shares. We do not know how long the Selling Stockholder will hold the Shares before selling them,
and we currently have no agreements, arrangements or understandings with the Selling Stockholder regarding the sale or other disposition
of any of the Shares. The Shares covered hereby may be offered from time to time by the Selling Stockholder, provided that the Shares
may only be offered after due exercise of the Inducement Warrants pursuant to the terms of the Inducement Warrants and payment of the
exercise price. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The table below lists
the Selling Stockholder and other information regarding the beneficial ownership of the shares of common stock by the Selling Stockholder.
The second column lists the number of shares of common stock beneficially owned by the Selling Stockholder as of May 13, 2025. The third
column lists the Shares being offered by this prospectus by the Selling Stockholder. The fourth column reflects the number and percentage
of shares of common stock beneficially owned by the Selling Stockholder, assuming the sale of all of the Shares offered by the Selling
Stockholders pursuant to this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The information set forth
below is based upon information obtained from the Selling Stockholder. The percentages of common stock beneficially owned after the offering
by each Selling Stockholder set forth below are based on an aggregate of 114,803,781 shares of our common stock, which is based on 74,868,935
shares of our Class&nbsp;B common stock and 39,934,846 shares of the Company&rsquo;s Class&nbsp;A common stock issued and outstanding
as of May 13, 2025. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> Name of Selling&nbsp;Stockholders </td><td style="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Common<br> Stock<br> Beneficially<br>
    Owned<br> Before<br> Offering </td><td style="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </td><td style="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Common<br> Stock that<br>
    May<br> Be Offered<br> Pursuant to<br> Prospectus </td><td style="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </td><td style="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Common Stock<br> Beneficially<br>
    Owned After<br> Offering<sup>(1)</sup> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom">
    <td> &nbsp; </td><td style="padding-bottom: 1.5pt"> &nbsp; </td>
    <td colspan="2"> &nbsp; </td><td style="padding-bottom: 1.5pt"> &nbsp; </td><td style="padding-bottom: 1.5pt"> &nbsp; </td>
    <td colspan="2"> &nbsp; </td><td style="padding-bottom: 1.5pt"> &nbsp; </td><td style="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Number </td><td style="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </td><td style="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Percentage<br> (%) </td><td style="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -10pt; padding-left: 10pt"> <font style="font-size: 10pt">Armistice Capital
    Master Fund Ltd</font><font style="font-family: Times New Roman, Times, Serif">.</font> <font style="font-size: 10pt"><sup>(2)</sup></font> </td><td style="width: 1%"> &nbsp; </td>
    <td style="width: 1%; text-align: left"> &nbsp; </td><td style="width: 9%; text-align: right"> 2,699,797 </td><td style="width: 1%; text-align: left"> <sup>(3)</sup> </td><td style="width: 1%"> &nbsp; </td>
    <td style="width: 1%; text-align: left"> &nbsp; </td><td style="width: 9%; text-align: right"> 2,699,797 </td><td style="width: 1%; text-align: left"> &nbsp; </td><td style="width: 1%"> &nbsp; </td>
    <td style="width: 1%; text-align: left"> &nbsp; </td><td style="width: 9%; text-align: right"> &mdash;<font style="font-size: 10pt">&ensp;</font> </td><td style="width: 1%; text-align: left"> &nbsp; </td><td style="width: 1%"> &nbsp; </td>
    <td style="width: 1%; text-align: left"> &nbsp; </td><td style="width: 9%; text-align: right"> &mdash;<font style="font-size: 10pt">&ensp;</font> </td><td style="width: 1%; text-align: left"> &nbsp; </td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"> <font style="font-size: 10pt">*</font> </td><td style="text-align: justify"> <font style="font-size: 10pt">Less
                                            than 1%</font> </td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"> <font style="font-size: 10pt">(1)</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Assumes that all the Shares of the Selling Stockholder covered by
    this prospectus are sold and that the Selling Stockholder does not acquire any additional shares of common stock before the completion
    of this offering. However, as each Selling Stockholder can offer all, some or none of its Shares, no definitive estimate can be given
    as to the number of Shares that the Selling Stockholder will ultimately offer or sell under this prospectus.</font> </td></tr>
  <tr style="vertical-align: top">
    <td> <font style="font-size: 10pt">(2)</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Such securities are directly held by Armistice Capital Master Fund
    Ltd., a Cayman Islands exempted company (the &ldquo;Master Fund&rdquo;), and may be deemed to be beneficially owned by: (i) Armistice
    Capital, LLC (&ldquo;Armistice Capital&rdquo;), as the investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing
    Member of Armistice Capital. The warrants are subject to a beneficial ownership limitation of 4.99%, which such limitation restricts
    the Selling Stockholder from exercising that portion of the warrants that would result in the Selling Stockholder and its affiliates
    owning, after exercise, a number of shares of common stock in excess of the beneficial ownership limitation. The address of Armistice
    Capital Master Fund Ltd. is c/o Armistice Capital, LLC, 510 Madison Avenue, 7th Floor, New York, NY 10022.</font> </td></tr>
  <tr style="vertical-align: top">
    <td> <font style="font-size: 10pt">(3)</font> </td>
    <td style="text-align: justify"> <font style="font-size: 10pt">Represents 2,699,797 shares of Class B Common Stock issuable upon
    exercise of the Inducement Warrants. </font> </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_007"></a> <b>PLAN OF DISTRIBUTION</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The Selling Stockholder
may sell all or a portion of the Shares beneficially owned by them and offered hereby from time to time directly or through one or more
underwriters, broker-dealers or agents. If the Shares are sold through underwriters or broker-dealers, the Selling Stockholder will be
responsible for underwriting discounts (it being understood that the Selling Stockholder shall not be deemed to be an underwriter solely
as a result of its participation in this offering) or commissions or agent&rsquo;s commissions. The Shares may be sold on any national
securities exchange or quotation service on which the securities may be listed or quoted at the time of sale, in the over-the-counter
market or in transactions otherwise than on these exchanges or systems or in the over-the-counter market and in one or more transactions
at fixed prices, through distributions in kind for no consideration, at prevailing market prices at the time of the sale, at varying
prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses
or block transactions. The Selling Stockholder may use any one or more of the following methods when selling or otherwise transferring
Shares: </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> ordinary brokerage
                                            transactions and transactions in which the broker-dealer&nbsp;solicits purchasers; </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> block trades
                                            in which a broker-dealer&nbsp;will attempt to sell the Shares as agent but may purchase a
                                            position and resell a portion of the block as principal to facilitate the transaction; </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> sales to a broker-dealer&nbsp;as
                                            principal and the resale by the broker-dealer&nbsp;of the Shares for its account; </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> an exchange
                                            distribution in accordance with the rules of the applicable exchange if we are listed on
                                            an exchange at the time of sale; </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> privately negotiated
                                            transactions, including gifts; </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> covering short
                                            sales made after the date of this prospectus; </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> pursuant to
                                            an arrangement or agreement with a broker-dealer&nbsp;to sell a specified number of such
                                            Shares at a stipulated price per Share; </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> a combination
                                            of any such methods of sale; and </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"> &#9679; </td><td style="text-align: justify"> any other method
                                            of sale permitted pursuant to applicable law. </td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> To the extent permitted
under Rule&nbsp;144, the Selling Stockholder may also sell the Shares owned by it pursuant to Rule&nbsp;144 rather than pursuant to this
prospectus. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Broker-dealers&nbsp;engaged
by the Selling Stockholder may arrange for other broker-dealers&nbsp;to participate in sales. Broker-dealers&nbsp;may receive commissions
or discounts from the Selling Stockholder (or, if any broker-dealer&nbsp;acts as agent for the purchaser of Shares, from the purchaser)
in amounts to be negotiated. The Selling Stockholder does not expect these commissions and discounts to exceed what is customary in the
types of transactions involved. The Selling Stockholder is not an affiliate of any broker-dealer. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The Selling Stockholder
may from time to time pledge or grant a security interest in some or all of the Shares owned by them and, if the Selling Stockholder
defaults in the performance of the secured obligations, the pledgees or secured parties may offer and sell the Shares from time to time
under this prospectus, or under an amendment to this prospectus under Rule&nbsp;424(b)(3)&nbsp;or other applicable provision of the Securities
Act of 1933, as amended, (the &ldquo;Securities Act&rdquo;) amending the list of selling stockholders to include the pledgee, transferee
or other successors in interest as Selling Stockholder under this prospectus. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In connection with the
sale of the Shares or interests therein, the Selling Stockholder may enter into hedging transactions with broker-dealers&nbsp;or other
financial institutions which may in turn engage in short sales of the Shares in the course of hedging the positions they assume. The
Selling Stockholder may, after the date of this prospectus, also sell the Shares short and deliver these securities to close out its
short positions, or lend or pledge its Shares to broker-dealers&nbsp;that in turn may sell these securities. The Selling Stockholder
may also enter into option or other transactions with broker-dealers&nbsp;or other financial institutions or the creation of one or more
derivative securities which require the delivery to such broker-dealer&nbsp;or other financial institution of the Shares offered by this
prospectus, which such broker-dealer&nbsp;or other financial institution may resell pursuant to this prospectus (as supplemented or amended
to reflect such transaction). </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The Selling Stockholder
also may transfer the Shares in other circumstances, in which case the transferees, pledgees or other successors in interest will be
the selling beneficial owners for purposes of this prospectus. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The Selling Stockholder
and any broker-dealers&nbsp;or agents that are involved in selling the Shares may be deemed to be &ldquo;underwriters&rdquo; within the
meaning of the Securities Act in connection with such sales. In such event, they will be subject to the prospectus delivery requirements
of the Securities Act, any commissions received by such broker-dealers&nbsp;or agents and any profit on the resale of the Shares purchased
by them may be deemed to be underwriting commissions or discounts under the Securities Act, and federal securities laws, including Regulation&nbsp;M,
may restrict the timing of purchases and sales of the Shares by the Selling Stockholder and any other persons who are involved in the
distribution of the Shares pursuant to this prospectus. The Selling Stockholder has informed us that it does not have any agreement or
understanding, directly or indirectly, with any person to distribute the Shares. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We may be required to
amend or supplement this prospectus in the event that (a)&nbsp;a Selling Stockholder transfers securities under conditions which require
the purchaser or transferee to be named in the prospectus as a Selling Stockholder, in which case we will be required to amend or supplement
this prospectus to name the Selling Stockholder, or (b)&nbsp;the Selling Stockholder sells the Shares to an underwriter, in which case
we will be required to amend or supplement this prospectus to name the underwriter and the method of sale. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We are paying all fees
and expenses incident to the registration of the Shares. We have agreed to indemnify the Selling Stockholder against certain losses,
claims, damages and liabilities, including liabilities under the Securities Act. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_008"></a> <b>LEGAL MATTERS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The validity of the Shares
offered by this prospectus will be passed upon for us by Fennemore Craig, P.C., Las Vegas, Nevada. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_009"></a> <b>EXPERTS</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Our audited consolidated
financial statements as of September&nbsp;30, 2024 and 2023 and for the two&nbsp;years then ended have been incorporated by reference
into this prospectus and the registration statement of which it forms a part in reliance upon the report of Bush&nbsp;&amp; Associates
CPA, independent registered public accounting firm and upon the report of such firm given upon the authority of said firm as experts
in accounting and auditing. </P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_010"></a> <b>WHERE YOU CAN FIND ADDITIONAL INFORMATION</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We file annual, quarter
and periodic reports, proxy statements and other information with the SEC using its EDGAR system. The SEC maintains a web site that contains
reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address
of such site is http//www.sec.gov. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><a name="s_011"></a> <b>INCORPORATION OF DOCUMENTS BY REFERENCE</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We are &ldquo;incorporating
by reference&rdquo; in this prospectus certain documents we file with the SEC, which means that we can disclose important information
to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this
prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will
automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports
that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the
old information. All filings we file pursuant to the Exchange Act after the date of the registration statement of which this prospectus
forms a part and prior to effectiveness of the Registration Statement
shall be deemed to be incorporated by reference into the prospectus. We have filed or may file the following documents with the SEC and
they are incorporated herein by reference as of their respective dates of filing. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"> 1. </td><td style="text-align: justify"> Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1963685/000121390025003458/ea0226831-10k_richtech.htm">Form
                                            10-K</A> for the year ended September 30, 2024, filed with the SEC on January 14, 2025, as
                                            amended on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1963685/000121390025011327/ea0230367-10ka1_richtech.htm">Form
                                            10-K/A</A> on February 7, 2025 and further amended on March 4, 2025; </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"> 2. </td><td style="text-align: justify"> Our Quarterly Reports on Form
                                            10-Q for the period ended <A HREF="http://www.sec.gov/Archives/edgar/data/1963685/000121390025014251/ea0230932-10q_richtech.htm">December 31, 2024</A> and March 31, 2025, filed with the SEC on
                                            February 14, 2025 and May 14, 2025, respectively; and </td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
<TD STYLE="width: 0.5in"></td><TD STYLE="width: 0.25in"> 3. </td><TD STYLE="text-align: justify"> Our Current Reports on Form 8-K filed
                                            with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390024089677/ea0218284-8k_richtech.htm">October 22, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390024092915/ea0219333-8k_richtech.htm">October 31, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1963685/000121390025011887/ea0230588-8k_richtech.htm">February
                                            11, 2025</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/1963685/000121390025031633/ea0238240-8k_richtech.htm">April
                                            14, 2025</A>, respectively.&nbsp; </td></tr>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp;&nbsp;&nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> All documents that we
filed with the SEC pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act subsequent to the date of this registration statement
and prior to the filing of a post-effective amendment to this registration statement that indicates that all securities offered under
this prospectus have been sold, or that deregisters all securities then remaining unsold, will be deemed to be incorporated in this registration
statement by reference and to be a part hereof from the date of filing of such documents. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Any statement contained
in a document incorporated or deemed to be incorporated by reference in this prospectus shall be deemed modified, superseded or replaced
for purposes of this prospectus to the extent that a statement contained in this prospectus, or in any subsequently filed document that
also is deemed to be incorporated by reference in this prospectus, modifies, supersedes or replaces such statement. Any statement so
modified, superseded or replaced shall not be deemed, except as so modified, superseded or replaced, to constitute a part of this prospectus.
None of the information that we disclose under Items 2.02 or 7.01 of any Current Report on Form 8-K or any corresponding information,
either furnished under Item 9.01 or included as an exhibit therein, that we may from time to time furnish to the SEC will be incorporated
by reference into, or otherwise included in, this prospectus, except as otherwise expressly set forth in the relevant document. Subject
to the foregoing, all information appearing in this prospectus is qualified in its entirety by the information appearing in the documents
incorporated by reference. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> You may request, orally
or in writing, a copy of these documents, which will be provided to you at no cost (other than exhibits, unless such exhibits are specifically
incorporate by reference), by contacting General Counsel, c/o Richtech Robotics Inc., at 4175 Cameron St Ste 1, Las Vegas, NV 89103.
Our telephone number is (866) 236-3835. Information about us is also available at our website at <i>www.richtechrobotics.com</i>. However,
the information in our website is not a part of this prospectus and is not incorporated by reference. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 14. Other Expenses of Issuance and Distribution.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is paying all
expenses of the offering. The following table sets forth all expenses to be paid by the registrant. All amounts shown are estimates except
for the registration fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"> SEC registration fee </td><td style="width: 1%"> &nbsp; </td>
    <td style="width: 1%; text-align: left"> $ </td><td style="width: 9%; text-align: right"> 31,445.85 </td><td style="width: 1%; text-align: left"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td> Printing </td><td> &nbsp; </td>
    <td style="text-align: left"> &nbsp; </td><td style="text-align: right"> <font style="font-size: 10pt">*</font> </td><td style="text-align: left"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"> Legal fees and expenses </td><td> &nbsp; </td>
    <td style="text-align: left"> $ </td><td style="text-align: right"> 35,000 </td><td style="text-align: left"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"> Accounting fees and expenses </td><td> &nbsp; </td>
    <td style="text-align: left"> $ </td><td style="text-align: right"> 6,000 </td><td style="text-align: left"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"> Trustees&rsquo; Fees and Expenses </td><td> &nbsp; </td>
    <td style="text-align: left"> &nbsp; </td><td style="text-align: right"> <font style="font-size: 10pt">*</font> </td><td style="text-align: left"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"> Warrant Agent Fees and Expenses </td><td> &nbsp; </td>
    <td style="text-align: left"> &nbsp; </td><td style="text-align: right"> <font style="font-size: 10pt">*</font> </td><td style="text-align: left"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"> Miscellaneous </td><td style="padding-bottom: 1.5pt"> &nbsp; </td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> <font style="font-size: 10pt">*</font> </td><td style="padding-bottom: 1.5pt; text-align: left"> &nbsp; </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"> Total </td><td style="padding-bottom: 4pt"> &nbsp; </td>
    <td style="border-bottom: Black 4pt double; text-align: left"> $ </td><td style="border-bottom: Black 4pt double; text-align: right"> 72,360.71 </td><td style="padding-bottom: 4pt; text-align: left"> &nbsp; </td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be estimated at this time. The applicable prospectus supplement will set forth the estimated amount of expenses of any offering of securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 15. Indemnification of Directors and Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s charter
and bylaws limit the directors&rsquo; liability and may indemnify directors and officers to the fullest extent permitted under the NRS
78.7502-NRS 78.751.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nevada law, NRS 78.138, provides
that the Company&rsquo;s directors and officers will not be personally liable to us, our stockholders or our creditors for damages for
any act or omission in his or her capacity as a director or officer other than in circumstances where the director or officer breaches
his or her fiduciary duty to us or our stockholders and such breach involves intentional misconduct, fraud or a knowing violation of law
and the trier of fact determines that the presumption that he or she acted in good faith, on an informed basis and with a view to the
interests of the corporation has been rebutted, or with respect to payment of dividends in violation of the NRS. While Nevada law allows
the articles of incorporation of a corporation to provide for greater liability of the corporation&rsquo;s directors and officers, our
second amended and restated articles of incorporation does not provide for greater liability of our officers and directors than is provided
under Nevada law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nevada law allows a corporation
to indemnify officers and directors for actions pursuant to which a director or officer either would not be liable pursuant to the limitation
of liability provisions of Nevada law or where he or she acted in good faith and in a manner which he or she reasonably believed to be
in or not opposed to our best interests, and, in the case of an action not by or in the right of the corporation and with respect to any
criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As permitted by Nevada law
or our charter, our bylaws (a) include provisions that eliminate the personal liability of our directors or officers for damages resulting
from certain breaches of fiduciary duties as a director or officer; (b) require the Company to indemnify and hold harmless any officer
or director against all expense, liability and loss (including, without limitation, attorneys&rsquo; fees, judgments, fines, taxes, penalties,
and amounts paid or to be paid in settlement) reasonably incurred or suffered by the indemnitee in connection with any threatened, pending,
or completed action, suit or proceeding (including, without limitation, an action, suit or proceeding by or in the right of the company),
whether civil, criminal, administrative, or investigative; and (c) require us to advance expenses of the indemnitee as such expenses are
incurred upon receipt of an undertaking by or on behalf of the indemnitee to repay the amount if it is ultimately determined by a court
of competent jurisdiction that he or she is not entitled to be indemnified by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 48; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The effect of these provisions
is to restrict our rights and the rights of our stockholders in derivative suits to recover damages against a director or officer for
breach of fiduciary duties as a director or officer. In addition, the Company pays the costs of settlement and damage awards against directors
and officers pursuant to these indemnification provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These limitations of liability
do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive
relief or recession.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has obtained
a directors&rsquo; and officers&rsquo; insurance policy pursuant to which our directors and officers are insured against liability for
actions taken in their capacities as directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 16. Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following exhibits are
filed with this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The agreements included or
incorporated by reference as exhibits to this registration statement contain representations and warranties by each of the parties to
the applicable agreement. These representations and warranties were made solely for the benefit of the other parties to the applicable
agreement and (i) were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one
of the parties if those statements prove to be inaccurate; (ii) may have been qualified in such agreement by disclosures that were made
to the other party in connection with the negotiation of the applicable agreement; (iii) may apply contract standards of &ldquo;materiality&rdquo;
that are different from &ldquo;materiality&rdquo; under the applicable securities laws; and (iv) were made only as of the date of the
applicable agreement or such other date or dates as may be specified in the agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned registrant
acknowledges that, notwithstanding the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional
specific disclosures of material information regarding material contractual provisions are required to make the statements in this registration
statement not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="text-align: left; width: 9%; vertical-align: bottom"><font style="font-size: 10pt"><b>Exhibit </b></font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="text-align: justify; width: 90%">&nbsp;</td></tr>
  <tr>
    <td style="border-bottom: black 1.5pt solid; text-align: left; vertical-align: bottom"><font style="font-size: 10pt"><b>Number</b></font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify; border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>Description of Document</b></font></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">1.1&nbsp;</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Form of Underwriting Agreement**</font></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">4.1</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Form of Certificate of Designation of Preferred Stock**</font></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">4.2</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Form of Stock Purchase Contract**</font></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">4.3</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Form of Warrant Agreement and Form of Warrant Certificate**</font></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">4.4</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Form of Subscription Rights Agreement and Form Subscription Rights
    Certificate**</font></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">4.5</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1963685/000121390025011362/ea023026101ex4-5_richtech.htm"><font style="font-size: 10pt">Form
    of Indenture*</font><font style="font-size: 10pt">**</font></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">4.6</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Form of Note**</font></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">4.7</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Form of Debt Securities**</font></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"> <font style="font-size: 10pt">4.8</font> </td>
    <td> &nbsp; </td>
    <td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/0001963685/000121390025011887/ea023058801ex4-1_richtech.htm"><font style="font-size: 10pt">Form
    of Inducement Warrant (Incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K filed with the
    SEC on February 11, 2025)</font></a> </td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">5.1</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390025033111/ea023863001ex5-1_richtech.htm">Opinion of Fennemore Craig, P.C.***</A></font></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"> <font style="font-size: 10pt">5.2</font> </td>
    <td> &nbsp; </td>
    <td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/1963685/000121390025011362/ea023026101ex5-2_richtech.htm"><font style="font-size: 10pt">Opinion
    of Ellenoff Grossman &amp; Schole LLP***</font></a> </td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"> <font style="font-size: 10pt">10.1</font> </td>
    <td> &nbsp; </td>
    <td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/0001963685/000121390025011887/ea023058801ex10-1_richtech.htm"><font style="font-size: 10pt">Form
    of Inducement Letter (Incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K filed with the
    SEC on February 11, 2025)</font></a> </td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">12.1</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Computation of Ratio of Earnings to Fixed Charges**</font></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"> <FONT STYLE="font-size: 10pt">23.1</FONT> </td>
    <td> &nbsp; </td>
    <td style="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390025033111/ea023863001ex23-1_richtech.htm">Consent of Bush &amp; Associates CPA, Independent Registered Public Accounting Firm***</A></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"> <FONT STYLE="font-size: 10pt">23.4</FONT> </td>
    <td> &nbsp; </td>
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390025033111/ea023863001ex5-1_richtech.htm">Consent of Fennemore Craig, P.C. (included in Exhibit 5.1)***</A></FONT> </td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"> <font style="font-size: 10pt">23.5</font> </td>
    <td> &nbsp; </td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1963685/000121390025011362/ea023026101ex5-2_richtech.htm"> <font style="font-size: 10pt">Consent
    of Ellenoff Grossman &amp; Schole LLP (included in Exhibit 5.2)***</font> </a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">24.1</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1963685/000121390025011362/ea0230261-s3_richtech.htm#a_013"><font style="font-size: 10pt">Power of Attorney (included in Part II of this
    Registration Statement)*</font><font style="font-size: 10pt">**</font></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">25.1</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Statement of Eligibility of trustee on Form T-1**+</font></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><font style="font-size: 10pt">107</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1963685/000121390025011362/ea023026101ex-fee_richtech.htm">Calculation of Filing Fee Table***</A></font></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <td style="text-align: left; width: 0.3in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <td><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</FONT></TD></TR>
  <TR>
    <td>&nbsp;</TD>
    <td>&nbsp;</TD></TR>
  <TR>
    <td style="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">** </FONT></TD>
    <td style="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If applicable, to be filed by an amendment or as an exhibit to a report pursuant to section 13(a) or section 15(d) of the Exchange Act and incorporated by reference</FONT></TD></TR>
  <TR>
    <td>&nbsp;</TD>
    <td>&nbsp;</TD></TR>
  <tr>
    <td> *** </td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> Previously filed. </p>
</td></tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <TR>
    <td style="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <td><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To be filed pursuant to Rule 305(b)(2) of the Trust Indenture Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 17. Undertakings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: -4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: -4.5pt">(a) The undersigned
Registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) To file, during any period
in which offers or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(i) to include
any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(ii) to reflect in the prospectus
any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than a 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the
effective registration statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(iii) to include any material
information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to
such information in the registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><I>provided</I>, <I>however</I>, that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post-effective amendment by
those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant
to Rule 424(b) that is part of the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) That, for the purpose
of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) That, for the purpose
of determining liability under the Securities Act of 1933 to any purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Each prospectus filed by
the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus
was deemed part of and included in the registration statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) Each prospectus required
to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an
offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the
Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form
of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the
prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date
shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which
that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made
in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that
was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately
prior to such effective date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) That, for the purpose
of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities,
the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to
such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Any preliminary prospectus
or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) Any free writing prospectus
relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) The portion of any other
free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) Any other communication
that is an offer in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby undertakes
that, for purposes of determining any liability of the registrant under the Securities Act of 1933, each filing of the registrant&rsquo;s
annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of
an employee benefit plan&rsquo;s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated
by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Insofar as indemnification for liabilities
arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to
the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) The undersigned registrant hereby undertakes
to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the
Trust Indenture Act in accordance with the rules and regulations prescribed by the SEC under Section 305(b)(2) of the Trust Indenture
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to the requirements
of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Santa Clara, State of California, on this 14th day of May, 2025. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RICHTECH ROBOTICS INC.</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Zhenwu Huang</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhenwu Huang</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chairman</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and
on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 30%; border-bottom: black 1.5pt solid"> <FONT STYLE="font-size: 10pt"><B>Name</B></FONT> </td>
    <td style="white-space: nowrap; width: 1%"> &nbsp; </td>
    <td style="width: 45%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Position</B></FONT> </td>
    <td style="white-space: nowrap; width: 1%"> &nbsp; </td>
    <td style="width: 23%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Date</B></FONT> </td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-top: 8pt"> <FONT STYLE="font-size: 10pt">/s/ Zhenwu Huang</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Chief Executive Officer and Chairman</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: center"> May 14, 2025 </td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt">Zhenwu Huang</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-top: 8pt"> <FONT STYLE="font-size: 10pt">*</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: center"> May 14, 2025 </td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt">Zhenqiang Huang</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt">(Principal Financial and Accounting Officer)</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-top: 8pt"> <FONT STYLE="font-size: 10pt">*</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Director</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: center"> May 14, 2025 </td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt">John Shigley</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-top: 8pt"> <FONT STYLE="font-size: 10pt">*</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Director</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: center"> May 14, 2025 </td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt">Stephen Markscheid</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-top: 8pt"> <FONT STYLE="font-size: 10pt">*</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Director</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td style="padding-top: 8pt; text-align: center"> May 14, 2025 </td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"> <FONT STYLE="font-size: 10pt">Saul Factor</FONT> </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td>
    <td style="white-space: nowrap"> &nbsp; </td>
    <td> &nbsp; </td></tr>
  </table>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; font-size: 10pt"> <font style="font-size: 10pt">* By: </font> </td>
    <td style="border-bottom: Black 1.5pt solid; width: 35%; font-size: 10pt"> <font style="font-size: 10pt; text-decoration: none">/s/
    Zhenwu Huang</font> </td>
    <td style="width: 60%"> &nbsp; </td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"> <font style="font-size: 10pt">Name:</font> </td>
    <td style="font-size: 10pt"> <font style="font-size: 10pt">Zhenwu Huang</font> </td>
    <td> &nbsp; </td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="font-size: 10pt"> <font style="font-size: 10pt">Attorney-in-fact</font> </td>
    <td> &nbsp; </td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">II-5</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &( 8@# 2(  A$! Q$!_\0
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MOP-5ECST%.>U68!)(PP]#6*H4;W<$S3FJ)>[*Q5U*P;Q*%N['4GO+H+M:WF
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MVQ/M./\ "I=2)216M5.X=<]N17;:!$-V><=_F%<E;Z'KZ7LMI_98W1*'9C(
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M@/'4!A3S K16^1]V(8]NM-*<XQ3W))+C5&GQYBKGV-5DD$LF .M13VR3*?E
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M_OL@@\^E5M/\:WMK<!;&W$4LI"?++C/IVJ.3WKCYO=L>U66GG3KT,TG,KE@
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M?&\^CZ;!:QN $CP(I?F0G^E%>94KU.9^Z>E3HPY5[QER^+M;NB%%Q$K$\>7
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M4@N@VA7!7&!SFHL0XI+0)'CD3<Q&7A1SGU'>G:5<);ZBK;AAA@C/K5>*)&5
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MV/EI<7:ZA Y+M&ULR,!CJ,,.E<__ &/,I20'<",X8_I6M9>'=?F@79I=S-&
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MOI6T^^^RLD,N3$JG(=<@;OS!J7PM(MQX]TPJ01]LX([]:]$X6>MZR,6U^?\
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M;7!<#SR1Z**G%LB<RSR?0<5FQZO)OW*.3Z\42WEQ+R44T[2ZBO'H2W$5IOW
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MZ'\:Z@1/( Z#*GHPZ&NFO%.=V8X=VA9&H_V65OF*9]0<55GLE/\ JI5/LQJ
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M] *RX&U"V^7RBT?]W_"KR7.]<$E3Z-P:Y90:V.E23$>!,'D_B>E8&JV?DO\
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,#[9HHHK&[+Y4?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #; G # 2(  A$! Q$!_\0
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M&:JQ/-<(KQVXVL,C,RBI;J;:IJSH=K<)I<9-A)*D@#J5(&[V/MWJHKN"5^I
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M/^__ "%8P)#2$C^\/_1E;GBI?]!B/^TP_P#'36+G+,<=2?\ V>N>>YT0V+H
MW+[R?^S'_&N<\21FX\-V:9Q\\9ZXS^Z'^%=#&=SKZ>8/_0Q_C6/K"G_A&[<Y
M.0T70 X^0BG3^)!4^%G):3IZSZE!#)&<,^.>]=Y%86D4:A;9!@>F:Y.QC/\
M:UM(&QB0'IUSFNY"Y4'VKLDSACL51$B?=C4#V%-9!FK92F&.E<M%4K43+5PI
M[5&R4AF/=*?.7Z4P*:MW:?O5^E1!<TK@(J4_;BGJN*<!DT7&,44\+[4]4YJ0
M)FD!'M&.E1.OM5O93'04 .\/&0>)]/$3!'+.-Q'0;&S7I%F+=KR2%9#/<Q >
M8S#.TGD#T'':O/O#L)?Q18$8VHSLV?38U>@VEJWVV2Z"1[-S3!EX).,#-=E&
MFY+4QDTF7DA9V?<<KGBJ3+Y<LB(G$C#/YU#>SM-IB13R&%YI%#^7D@KU(SV[
M"IK0J40!E90^%V]ESP/RJJ\.2*:)IMN3OM8W?,"RE?WA_#(JMJ;0-ISM/"TD
M0=<H<J2<C'ZU,TZ)(0(IRV2.$)';_&B*47:$2VTB+Z3+C.#Z?AFMCCU6I+.6
M$@Q&K/ZEL8H);:Q*XP,CGK4CY(W;06_6H-S \C'MG-.RL+F..\:W?VOX=7%R
M4,8D:/Y2,8_>K7E+S_,>>YKUSXB@R^$)8@>9+FW0?4R"N8TSX733N'O]6B3!
MR5@0MWZ9.*X:\'9)GLY?7A34FS"\-:<]_J+/-I\MU:K;RM_JV*;PI*\CWKU>
MTT'27TJV:/388)G@17<1X="!V].<UBW-U9Z1JW]E&YO2RX8 LL</(XX''%;5
MH9G6>WE(9<*P9&!VGTXZ?6N*E7E"=I*R[FN*G&O&T7<GUKS'?3A(S+OU"+ !
M^\!D\_E6D+9/M!D;:"6)R'.:PK^9[_5]$CACD98+LO,X3Y5 4XY_&MU(4-P[
MYP<D_*^3GZ8KV*5N16=SP96YF&HVL=Q9&.:1XH^#O#8(_&JFFV=G96L[6MPT
MBR-EY"V_! Z59U"TAU&V$-QR@.1GIGWJO8Z3;Z;:S"%ES)RSD<?EFL6KUMOF
M;IKV>Y9AFC8E%EWGKTQ_2JE]::9-/NN]BS$ 9W8; JS;+"J,T3(V3]Y%P/I4
M%RNGBX_TEHA*0&P[8]@31B/AMI\QTM^OR.9^(X1/ _DVX!1[BW2-4YR-X/'K
MTK(\1R7%W=V%EH=A-!J)(E(7 ,)'4D@X%7OBC*(/#5FD>%S?P[-O&,9/%8^F
MZ[+);-I[W'D3RR;OM!./._V7/\NU<U=QNDSUL!0G.G.<-;&I=:I#9/';ZM=K
M?:JGW6\L""%__9FK-T_17U5YM0UUWCM)3AGD?F88Z 'IT/2KVH0:1X>E@O-1
M87NH[ ;>S3A%_P!H@]/J?PKA]0\3ZEK%S,)H727YHU'2..,]54=B?7O6?*EJ
MV=4*<ZEK*R[V_(]B\8RPW'PITN6WC,<#B QIZ+L.!^5>28^M>L>*"&^$.D%1
MP4M\#_@!KRK%*>YYS5FUYL3'UIV* *4"I&)CIS2@?6G8IV.:!7&8IVSW-."T
MX"F%R/;]?SHV_7\ZEVTFVD%R%EQGK^=02#_.:ME>M02K3 R;Q?E-2)I]U%X>
MM]0CE+1,,;%)RO.!^M)>+A#5S2]1OETBVTY((O+FW!)7)X^;G\JJT>5\Q5.4
ME/W34%D(7TV Q.TI&^1Q(1P/7\:V[W6K&!H[>[!82@EL<A?K5^ST)VMXTN+I
M)IE')9_7^E1WO@Z&\NT=;J%9 ,%-PR16BJ25Y0>CMH9NTI)2Z7(;;1[)+DRJ
M[2Q,NY8B<X^GK6SHMO'%+?16[F!OW;, "VTG/%5AI]SI2I!#/;F5VR&DQ@>P
MK9TR5)89'$D2S?QR!.H!QT]*UI.'.HK1[BK.3@V]4:%O'<$H7FC9.X\K!/ZU
MS-Q?>)F\0F&+3YUMEFQYF?D*9_7BNI@BD9M[31R)TPL>/US7-ZMK&N6VN&VL
M].N98%<#>D65(X[]#756M9;_ ".*D]6=#<PR-,5CNY(U; PJ9 _&L[7KB;2M
M),EH+B>0N!P-[ ?X5J2#,NT7#H3CY @(_/%97BK59]#T;[7:Q;Y#(J' Z#N:
MJ?PO44/B1A7%Y=WO@?6)+Q905C.PRIM8C'I7FL;*47+=A7H<>N7FO?#W6[B]
M@,<D2LJDC&Y<9KS*$_NT/^R*Q?PQ/5P2O4D7@Z8XIK,..>M1 TK=12Z'K\JL
M>B^%IKE/ 5S):R[);:[+XQ]X<?+]#4VM7]U=^&]2N9@D<#($2->2#D9^;O2_
M#A(+S0-2MI\M']H4LH..JUI^+6TZ#0)(GBD$>Y$")QWXQ6J:Y+G@5+_6.7S/
M/X=5DAM(X%LQ\L>W(S^?3]*2[U"6\\HO!PKB1EY(;V-:0GT)(POF7*2;0,&?
M&WVQBJ%[=:9D_9Y)LXZFX/\ A6:;/045>Z1S\>I^,[,_\?<\JCMYBO\ S%3Q
M^./%5J?WUFDH_P!NW_JIKJ%T0R*66X08 )1A\PR<<@55O-+ELT#2,A!.!M;-
M<CC)*[1\FLQFMT9L7Q-D8JE]I:(.[*[)_,&O0;.6*XM(KB!Q)%*H=74\$&O,
M-8B4Z9<^T9/-=UX-??X-TD_].X'Y$TD[GIX>O[:-S<IT8)--J2+[QH.D5E]J
MC(JP5XJ)EQ4,M,Y[Q0F=-4^CG_T%JP5SGIU/]3_C72^)$SI8)_OC^1KG(R&*
M>[#^8_QK">YO#8MVHW,I_P!I?_0HZR]4&?#L0X^_'D'OPW^%:]ME%3CN/_:=
M8^ME%\/Q%F(Q(G;_ 'Q13^)"J_ S"LALU2!0@P91DX-=W&F8U/L*X2RDV:C
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M+<22.9$#+&C$''\ZZR34;YU,4^XK)\NQEQD9^E<UKVI:IIVMSV\3JT:!/D4
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M'\1]?;V%6;>.RC *J0>W/2L(R[IBP'0G-3_:MH /YUH<Z5C<E6.\L)8H"5F
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M^;5]9BW>FF>%AM)-&Y/J$=C'&KE@7.,]L^],EO<20.AX)QUJAK#JUK*&&02
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M5_QIS:JJ_*][#]&D6E*5U9C2:=SAX&W1(S*$..AXIDI&[C 'KG-=N^I6TO\
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MN <[D/\ ,4A$DMU(?XJB2\E4]<_6F!XY.8Y4/U84ODS8SY+$>JC- 'NI;?\
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M)=7(/:[M!^6VFPDMJ%OGH=;E/Y1FED;-W<CIB_M1^BU';'-Y9>^L7!_\=84
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M5 ['(+=/!.4FSMSPY]?>MS3@)I& [H:LS:%YJMN3(IFF::;"Z8B8M&5P$?\
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MJZW6FTR3EW\-Z-H]S'J.GZ5'!<HV#)$&^52,$[<TR35(7N$D9P)"V N>"..
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0+:K<G[HC7Z+5.@TKDG__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
